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ABSTRACT  
 
Throughout the 20Pth P Century, female operatic singers in most of the major European opera 
houses were given “grace days” (where they were not required to sing) in recognition of 
the effect of hormonal changes on the singing voice. Financial constraints in professional 
companies have resulted in a reduction of such considerations, but to date, there has been 
no systematic study of the effects of hormonal fluctuations on the quality of the female 
singing voice, or of its potential adverse effects on the vocal apparatus for singers who are 
affected by pre-menstrual syndrome.  
 
This study investigated the effects of hormonal fluctuations on young professional female 
classical singers.  Female and male professional singers in training (students) at the 
Sydney Conservatorium of Music, University of Sydney, were asked to participate as 
volunteers in the study by keeping daily diaries. The female singers kept a diary for two 
separate months beginning on the first day of menstruation, in which they recorded their 
daily basal temperature, mood, voice state and physical well being. The male control 
subjects kept daily diaries for one month. Acoustic analysis of two vocal samples taken 
during the second month, on days 1 and 14 of the cycle, were completed on the six most 
severely affected female subjects, who were identified through their diary ratings of 
changes in vocal quality during menstruation.  
 
The selected students assessed their own vocal samples, presented in random order, to 
determine whether they could reliably identify which of their samples were affected by 
menstruation. Vocal staff at the Conservatorium (pedagogues), who were blind to the 
purpose of the study, also assessed recordings presented randomly. Results indicated that 
 ix 
self-perceived vocal quality varied over the course of the menstrual cycle, particularly 
during the first seven days of the cycle, that negative changes in mood affected the voice, 
and that fatigue, effort, hoarseness, weakness & peak performance were the most 
frequently affected vocal states. A surprising finding was that male self-perceived voice 
quality also varied over the course of one month of diary keeping. 
 
There was no consistent change in direction of scores during menstrual and non-menstrual 
phases. Five of the six most affected singers correctly identified their performance during 
menstruation but pedagogues were not consistently able to do so.. These results indicate 
that perceived quality of the voice through changes in the menstrual cycle may not be as 
obvious to a highly trained observer even though they were reliably perceived by the 
singer. 
 
This study demonstrates that menstruation has a discernible impact on the self-perception 
of female singers’ vocal quality and implies that the premenstrual or menstrual female may 
not feel able to present her peak performance at these times of hormonal fluctuation. 
Further detailed research in this area may be warranted on a larger scale to elaborate a 
more precise clinical management of the problem. 
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CHAPTER 1 
 
1.1 Background 
 
The human female menstrual cycle is a very complex physiological function that affects 
many body systems. While its effect on these various body systems is well understood, the 
effect of the hormone cycle on the singing voice in western classical singers has not been 
studied empirically. The research described in this thesis originated from my work and 
interest in young female professional singers and arose out of my personal experience as 
an expert pedagogue preparing these young singers for lives as professional western 
classical singers.  
 
During the course of many years’ experience, I have observed what I now consider to be a 
relationship between menstruation and an array of symptoms such as loss of voice quality, 
flexibility, range, stamina and support in some female singers. Some women appear to 
cope better with menstrual symptoms that affect their voices, and it is an open question as 
to whether this is due to greater experience and technical mastery, greater emotional 
control and maturity, or a combination of both factors. 
 
Both pre-menstrual and menopausal changes exert negative effects on the voice due to the 
temporary loss of oestrogen during the pre-menstrual phase and the permanent loss of 
oestrogen at menopause. Hormone replacement therapy is often prescribed to restore 
optimal hormone levels in both situations. In some singers, issues related to hormones and 
the menstrual cycle are critical to their professional careers, and pedagogues and coaches 
need to be aware of the vocal limitations that occur during these times. In the following 
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sections, each of the factors that affect the female singing voice will be described and their 
influences on vocal production and vocal quality highlighted. 
 
The aim of this study was to provide more specific information on the effects of hormonal 
fluctuations on the young professional singer, as there is very little singer relevant research 
in this area. As their body encompasses their entire instrument, any physical, physiological 
and emotional variation will affect their voice and further education and knowledge in this 
area is likely to be of benefit to singers and their teachers. 
 
The implications of the research are far reaching for both students of voice and for vocal 
pedagogues. This research hopes to increase specific knowledge in both singers and 
pedagogues about the effects of hormones on vocalization. This implies acquiring 
increased awareness about conditions that reduce performance skills in singers and thereby 
knowing when to lighten the vocal load to avoid potential trauma or permanent damage to 
the vocal apparatus. These factors are critical to the length and quality of a performing 
career and affect the consistency and reliability of the performer at all stages of her career. 
 
1.2 Literature Review: Previous studies  
 
The voice is an exquisite messenger of emotion (Sataloff, 1997). Frank (1931), who 
introduced the term “premenstrual tension”, described “a relationship between hormonal 
changes during the menstrual cycle and recurring psychological manifestations such as 
depression or irritability. These symptoms may vary monthly in incidence, number, and 
intensity among the affected and a given individual may experience marked variation from 
cycle to cycle because of factors such as stress, diet, age and general health.” 
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The significant proportion of training and research into the voice has involved finding the 
most appropriate methods for teaching vocal expertise for performance and determining 
how the instrument functions. Scant attention has been given to seeking information 
regarding the preservation of the vocal mechanism that we hope to use throughout many 
years in our career. It is well known in the industry, that many singers have short careers, 
or suffer fairly consistent injury or inconvenience due to fatigue and impairment of 
function. It is becoming recognized that anything that affects the body will, in turn, affect 
the voice. Laryngologists, physicians, speech pathologists and teachers of singing have all 
confirmed this lack of knowledge in the singing and speaking professions, as well as the 
medical profession. It is recognized that as the body is the encasement of the instrument, 
any benefit to a singer’s general health is a benefit to the voice. Arts medicine is now a 
multi-disciplinary field, while voice medicine has evolved quickly and dramatically 
improved the care of singers with problems. However, much deeper understanding of the 
effect of hormones on the voice is imperative, so that enhanced management of the 
symptoms may be addressed. 
 
Anecdotal evidence from the singing profession informs us that female singers are 
adversely affected by hormonal fluctuations as a result of the premenstrual syndrome. 
Singers are more sensitive to any change in their vocalization because of the complexity of 
the motor tasks required during singing and the profession is eager to be informed about 
the management of this problem. For those singers adversely affected, proper advice and 
management is essential, as the symptoms are cyclical and a significant proportion of their 
performing lives may be affected. .Very few studies have been undertaken that are helpful 
to the profession. In an ever-increasing competitive market, it is imperative that 
professional singers be able to project beautiful tone, consistency of volume and range 
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reliably in every performance. A singer’s personal performance quality will have 
variability within a narrow band, which is acceptable; however, any marked variation of 
standards in performing is not consistent with expectations of permanent employment in 
opera companies. Performance careers are stressful, not only because of the requirement to 
maintain the highest standards, but because there are fewer permanent contracts, 
significant public scrutiny, the demand for perfection and the constant competition among 
peers. Critics can exact a heavy toll professionally if a performance is berated publicly in 
print and this in turn can result in a significant loss of confidence in the singer. It can also 
have a detrimental effect regarding the employment of that singer by the same company 
for the following season. Performance anxiety may also be problematic, and may be 
compounded by an instrument that is inconsistent and unreliable in function, causing 
serious consequences that may have a deleterious impact on a singer’s career. 
 
The relatively few studies to date have generally used subjects who were non-singers. To 
use non-singers is not commensurate with the information sought by the profession, 
because professional singers use the instrument in a much more demanding way, over long 
periods of time and with highly complex motor tasks. An example of this type of study is 
Silverman and Zimmer (1978), who tested subjects to reveal whether most young women 
with normal speaking voices, but no vocal training, exhibit premenstrual hoarseness. The 
methodology was also non-specific for singers because the tasks were limited and non-
challenging. A professional singer uses extensive range, dynamics and volume, and the 
chosen tasks presented by the literature were neither exacting nor appropriate. 
 
The aims of the five other studies had a more homogenous focus. All studies aimed to 
determine objectively whether changes in voice quality accompany the hormonal changes 
 5 
during the menstrual cycle. In the study by Abitbol, Abitbol and Abitbol (1999), the vocal 
changes caused by hormonal fluctuations were to assess the prevalence of premenstrual 
hoarseness. In the Higgins and Saxman study (1989), it was to show that the vocal output 
alters because the mass of the vocal folds changes. Brown, Isenberger and Rothman (1985) 
wished to prove that singers with the most irregular menstrual cycles also experience the 
greatest vocal problems, whilst Chae, Choi, Choi, Jin and Kang (2001) sought to evaluate 
whether the presence of premenstrual syndrome affects female singers. Wicklund (1996) 
measured the correlation between premenstrual syndrome and vocal dysphonia. In essence, 
all the studies to date support the hypothesis that voice is affected by the menstrual cycle 
and its inherent physiological changes. 
 
The concern to the singing community is that so few singers have been tested and that the 
types of testing were not commensurate with the tasks that professional singers have to 
address every day of their working lives. For example, Higgins and Saxman (1989) used 
small number of subjects - ten young women and five young men aged 19-26 years.  They 
were all non-singers and were assessed using speech samples, specifically six vowel 
productions. None of the female subjects were taking the contraceptive pill. Temperature 
of the women was recorded daily to reveal ovarian hormonal fluctuation. Testing occurred 
every second day for thirty-three days. Results indicated that at the premenstruum and 
during the onset of menstruation, the magnitude of frequency perturbation (disturbance) 
was not notably different from the average, while at the time of ovulation there was a 
notable change for most subjects than by chance alone.  
 
In the study by Brown et al (1985), sixteen women aged between eighteen and twenty-two 
years were chosen. Some of the subjects were trained singers and some had no training.  
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No information as to which results belonged to which group was given, and again, with a 
percentage being untrained singers, the results represent a very small number of singers. 
All the subjects chosen had irregular menstrual cycle, which affected the results, as 
research has generally shown that the more irregular the cycles, the more the hormonal 
fluctuations negatively affect the voice. In this study, a small number of the subjects were 
also taking the contraceptive pill, but no exact figures were available. Again, the use of the 
contraceptive pill must have had an effect on the research, because the pill stabilizes the 
hormonal fluctuations and hence the voice. However, the vocal testing was more 
appropriate to that which should be utilized for professional singers. The subjects sang 
through chromatic scales and phrases where their voices revealed the most difficulty in 
phonation. It would have been interesting to ascertain how the untrained singers in the 
subject group coped with the singing task; however, no such specific information was 
available. 
 
Chae et al (2001) assessed 28 women over a two-month period, but again, all were non-
singers. They were female nurses aged 21-30 years. Their task involved producing five 
seconds of sustained sound on the “ah” vowel as in “father”, but testing such as this is 
inadequate for both singers and non-singers.. None of the subjects took the contraceptive 
pill and none was consistent in taking their daily basal temperature to plot their monthly 
hormonal changes. 
 
Similarly, Silverman and Zimmer (1978) chose non-singers for their study. Twenty 
undergraduate students aged between nineteen and thirty-six were the subject choices. The 
wide range of ages can create difficulty in interpreting the results because the known 
literature tells us that women manage their symptoms better with age. The other aspect is 
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that by thirty-six, some of these women may have borne children which may have a 
notable effect on their physiological status and thus on the results. Some consistency was 
noted in that none of the subjects was on the contraceptive pill and all took their daily 
basal temperature to plot the hormonal changes. Another consistency noted was that the 
subjects, being non-singers, were tested with speech samples of three-second duration. The 
chosen vowels were “ah”, “eu” and “u”. There were two samples taken, one at ovulation 
and the other at premenstruation. 
 
Abitbol et al (1999) tested 97 women, all vocal professionals aged from 23 to 36 years old. 
None of them was taking the contraceptive pill and all presented with a premenstrual 
dysphonia. The study involved measuring oestrogen and progesterone levels, as well as 
vocal fold smears and cervical smears. The vocal testing was by singing “Frère Jacques”, 
and although this French folk song is more challenging than speaking or sustaining five 
vowels, it is still far removed in difficulty from the daily expectations of a professional 
singer, showing limited range, volume expectation or technical challenge. 
 
Finally, in the study by Wicklund (1996), a group of 20 women were selected, aged 20 to 
57 years old. Again, the diversity of age group poses a problem with consistency of 
symptoms. As with the earlier study of Silverman and Zimmer (1978), many women in the 
older age group may have borne children affecting hormones, and indeed, those 
approaching 50 years of age in the group may well have consisted of a number who were 
already menopausal. The average age of menopause is between 45 and 55 years of age and 
there are many symptoms that reflect hormonal changes up to five years prior to  
menopause, so it is plausible that several of these subjects were inappropriate for the 
testing criteria. However, there was an excellent questionnaire on the premenstrual 
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syndrome. Several areas such as mood states, voice differences and general health were 
addressed, as well as specific questions covering premenstrual dysphonia.  Questions on 
general health included sleeping patterns, food cravings, headaches, smoking habits and 
exercise programs. The testing was done with acoustics as well as visual and glottographic 
testing. 
 
Many observers have reflected on the mood states investigated in this research. Chae et al 
(2001) observed that one or more of the four emotional components, sadness, tension, 
anxiety or conflict, are present along with the diagnostic criteria for premenstrual 
syndrome. Davis and Davis (1993) stated that the larynx is especially sensitive and 
vulnerable to fatigue and that an emotion such as anger will adversely affect the voice. 
Sommer (1978), in her paper on stress and menstrual disorder, describes women from 
many published papers reporting unpleasant symptoms such as stress, irritability, 
nervousness and depression associated with the premenstrual and menstrual phases of the 
cycle. 
 
A more recent study (Tepe, Deutsch, Sampson, Lawless, Reilly & Sataloff) in 2002, 
surveyed young choral singers, twenty-five years of age and younger, with a closed set 
questionnaire. Of almost twenty-three percent respondents, more than half reported that 
they had experienced vocal difficulties, concluding that it is common among young choral 
singers. Again, the perceptions that the singer’s voice felt worse in the morning and that 
chronic fatigue or insomnia are all risk factors in singers, cannot be extrapolated to young 
professional singers undergoing good vocal training. However, self-reported symptoms 
should alert both the singing teacher and the medical profession to potential problems of 
the individual singer. 
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1.3  The Human Female Menstrual Cycle 
 
The hormonal cycle in the female, from menarche (10-18 years) to menopause (45-55 
years), is controlled by ovarian oestrogen. The complexities of hormonal interactions 
throughout the lifespan including the menstrual cycle, pregnancy and puerperium (post-
natal) are controlled by changes in oestrogen secretion. Childhood and senescence are 
phases of minimal gonadal activity (Ganong, 1965). 
 
A gland is any cell or organ that secretes some substance (Nourse, 1965). The adrenal 
gland above the kidney secretes adrenaline; the salivary glands in the mouth secrete saliva. 
Endocrine glands (Martin, 1998) are the chemical regulators of bodily function and they 
secrete substances called hormones, which serve as their chemical messengers (from the 
Greek “hormon” meaning “arouse to activity”) (Nourse, 1965). Each gland exerts its 
significant effect through the hormone/s it secretes into the blood stream. Hormonal 
activity always remains in a delicate balance to maintain whole body equilibrium (Nourse, 
1965). 
 
Each hormone is a substance that is produced in a specific part of the body by an endocrine 
gland, such as the pituitary or ovary (Martin, 1998). It passes into the blood stream where 
it is carried to other distant (target) organs or tissues and acts to modify their structure or 
function. Examples of hormones are growth hormone from the pituitary, oestrogen or 
progesterone from the ovary and thyroxine from the thyroid gland. Most hormones are 
structurally quite different; however, adrenal cortical hormones and all the ‘sex’ steroids 
are very similar and are all derivatives of the basic cholesterol molecule (Stein, 1998). 
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There is very strong evidence that a direct connection exists between the endocrine glands, 
the brain and the entire nervous system. Neuro-hormones, which link the nervous system 
and the endocrine system, demonstrate this connection, but both systems are actually 
separate sections of one vast body-controlling system. The maintenance of the whole 
body’s total well-being depends upon each sector’s influence on the other, and in turn, 
each is dependent upon the functioning of the other. 
 
The hypothalamus is a region of the forebrain, below and between the two hemispheres, 
linked with the thalamus above and the pituitary gland below (Martin, 1998). It contains 
several important centres controlling body temperature, hunger and eating, thirst and water 
balance, as well as sexual function, and is closely connected with emotional activity and 
sleep. The region functions as a centre for the integration of hormonal and autonomic 
nervous activity through control of pituitary secretions (Martin, 1998).  A woman’s 
emotions can affect this part of the brain, which is demonstrated by the fact that 
menstruation can cease after a particularly strong emotional upset.  
 
The hypothalamus begins to secrete its releasing hormones about four years before 
menarche, which is the onset of the menstrual periods and production of other physical and 
mental changes associated with puberty (Martin, 1998). Menarche occurs when the 
reproductive organs become functionally active and may take place at any time between 
ten and eighteen years of age (Martin, 1998). The changes are due to a series of 
interactions between several glands in the body. The physical changes are evident in 
females with the development of breasts and hips as well as secondary sexual 
characteristics, which include pitch and timbre of the voice. 
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The hypothalamus controls temperature regulation in mammals (“warm-blooded” or 
homeothermic animals). A group of reflex responses controlled by the hypothalamus 
operates to maintain body temperature within a narrow range despite wide fluctuations in 
environmental temperature. Normal body temperature in well individuals, taken orally, can 
vary between 35.8 degrees and 37.2 degrees Celsius (centigrade). There is also diurnal 
variation (Rhoades & Pflanzer, 1992) wherein temperature rises gradually throughout the 
day towards evening and then drops slowly overnight to reach a minimum in the early 
hours of the morning. During ovulation, there is a brief drop in body temperature, followed 
by a sustained rise (Williams & Wendell-Smith, 1966), attributed to progesterone, which 
can be clinically measured. The mean body temperature after ovulation is approximately 
1Po PC higher than that before ovulation (Rhoades & Pflanzer, 1992). This is the reason why 
it is normal for women in the second half of the menstrual cycle to have a temperature up 
to 37.4 degrees Celsius. 
 
The pituitary gland is “the master endocrine gland of the body”, controlling many other 
endocrine glands through its secretions (Martin, 1998). It is a pea-sized, ductless gland 
attached beneath the hypothalamus and is positioned in a small bony cavity at the base of 
the skull. It has anterior and posterior lobes, which secrete different hormones into the 
blood stream. These hormones in turn are regulated by specific releasing hormones 
produced in the hypothalamus. It controls the hormone output of the thyroid gland, the 
adrenal glands and the gonads (ovaries and testes), as well as the natural circadian rhythm 
of the body. Consequently, it controls body growth, sexual maturation, reproduction and 
metabolism. 
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The ovarian and menstrual cycles are completely under the influence of anterior pituitary 
secretions, which in turn are controlled by the hypothalamus and the nervous system. 
Gonadotrophin-releasing hormone (GnRH) begins to be secreted by the hypothalamus 
after about the age of twelve. This causes certain specialized cells in the pituitary gland to 
produce the primary hormones that act on the female ovaries. There are essentially three 
pituitary gonadotrophins, FSH (follicle-stimulating hormone), LH (luteinizing hormone) 
and LTH (luteotrophic hormone). The hypothalamus also secretes appropriate releasing 
hormones, FSH-releasing factor and LH-releasing factor. 
 
FSH stimulates development and maturation of the ovarian follicle, along with production 
of ovarian oestrogen, and in turn is controlled by (‘feedback’) the amount of circulating 
oestrogen in the body. It also stimulates the testes to produce sperm in the male and the 
‘feedback’ is though levels of testosterone. LH has four functions closely related to the 
prior actions of FSH. It not only promotes ripening of the follicle but also its rupture. It 
induces the formation of the corpus luteum and the consequent production of oestrogen, as 
well as the production of testosterone in the male (Ganong, 1965). LTH stimulates the 
corpus luteum production of progesterone and the mammary gland production of milk. The 
two steroids secreted by the ovary, oestrogen and progesterone, feedback via blood 
concentrations to regulate the secretion of these gonadotrophic hormones.  
  
The autonomic nervous system involves sympathetic and parasympathetic functions, 
which are responsible for the control of the bodily functions that are not consciously 
directed (Martin, 1998). These functions include regular beating of the heart, intestinal 
movements, sweating, salivation and dilatation of the pupils. The two systems work in 
balance with each other to smoothly control the reflex actions of the body. They can also 
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be aroused to contribute to voluntary actions of the mind over the body like the classical 
“fight or flight” reactions. Herein, the human body responds to aggression by increasing 
heart rate and breathing, raising blood pressure, increasing muscle tension with dilatation 
of muscle blood supply and increasing blood sugar and body metabolic rate. 
 
The ovary is the primary female reproductive organ producing egg cells (ova) and steroid 
hormones. It responds to hormones (gonadotrophins) from the anterior pituitary in a 
regular cyclical manner. Each ovary contains numerous follicles, which secrete oestrogen 
and small amounts of androgen (male sex hormone) (Martin, 1998). After ovulation, the 
release of an oocyte (egg), a corpus luteum forms at the site of the ruptured ovarian 
follicle. The corpus luteum secretes progesterone in preparation for implantation of a 
fertilised egg. Oestrogen and progesterone together regulate changes in the uterus 
throughout the menstrual cycle and pregnancy. Although all parts of the female genital 
tract undergo periodic changes with the influence of oestrogen and progesterone, the most 
obvious effects occur on the lining of the uterus (endometrium) with the resultant 
menstruation in the non-pregnant female. 
 
Oestrogens are naturally occurring steroids secreted by ovarian follicles, the corpus 
luteum, the placenta, and, in small amounts, by the adrenal cortex and the testes. Their 
biosynthesis is via androgens (male sex hormones) and oestradiol is the main oestrogen 
secreted. Oestrone and its metabolite oestriol are the other oestrogens, in decreasing order 
of potency. Thereafter, there are at least ten different metabolites of oestradiol excreted in 
human urine (Nader, 1991). The principle effects of the oestrogens are exerted on the 
pituitary, the brain, the breasts and the female reproductive organs. Although these effects 
are multiple and varied the main control is upon ovarian follicle maturation and cyclical 
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changes in the endometrium. They have a ‘feedback’ effect on the pituitary 
gonadotrophins (FSH, LH and LTH) and increase libido in human females. The breast 
responds to oestrogens by enlargement at puberty and initial pigmentation of the areolae. 
The secondary sexual characteristics of female maturation, body configuration (narrow 
shoulders and broad hips, thighs that converge and hips that diverge), fat distribution 
(breasts and buttocks), hair distribution and the prepubertal proportions of the larynx, 
which retains the high-pitched female voice, are all results of oestrogen function. Various 
skin characteristics are also attributed to oestrogens as well as a significant cholesterol 
lowering effect in the blood. 
 
Progesterone is secreted by the corpus luteum and the placenta as well as being related to 
the biosynthesis of steroid hormones in the body. It is mainly responsible for changes in 
the endometrium, has an anti-oestrogenic effect on uterine muscle and stimulates growth 
of secretory tissue to produce breast milk. Progesterone causes thickening of the uterine 
lining and induces the glandular structures to secrete nutritious fluid to nourish the 
fertilised egg after implantation. In a ‘feedback’ cycle with the pituitary, progesterone 
inhibits LH secretion and appears to be the primary hormone in salt and water retention. 
When progesterone is secreted late in the menstrual cycle, it contributes to the well-known 
premenstrual tension syndrome. It is also responsible for the basal body temperature rise 
after ovulation, which can be plotted on a graph, relaxation of smooth muscle and increase 
in the oily secretions of the skin.  
 
Testosterone is the principal male sex steroid (androgen) and is synthesised from 
cholesterol in the Leydig cells of the testes. The biosynthetic pathway of all steroid 
hormones formed in endocrine glands (adrenal, testes and ovaries) is very similar, only 
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differing in the enzyme systems each uses. Testosterone is also formed in the adrenal 
cortex, where it is the precursor of the oestrogens (Ganong, 1965). Small amounts of 
oestrogens are formed in the testes as well. Androgens, including testosterone, exert a 
‘feedback’ inhibition on the secretion of LH from the pituitary. Their main actions are 
developing and maintaining the male sex organs and secondary male sexual 
characteristics, such as muscle development, hair distribution and depth of voice (Martin, 
1998). They also maintain protein anabolism (growth promotion) and to some extent are 
involved in maintaining spermatogenic cells in the testes.  
 
The menstrual cycle is the sequence of events in sexually mature non-pregnant women 
whereby an egg cell (ovum) is released from the ovary at regular intervals until the 
menopause (Martin, 1998). It is the recurring process of new oocyte formation, corpus 
luteum formation and ovarian hormone production. The cycle is usually divided into two 
phases – the follicular phase followed by the post-ovulatory luteal (progestational) phase 
of 11-14 days (Williams & Wendell-Smith, 1966). The full cycle usually lasts about 26-28 
days and varies in length dependent on the length of the follicular phase. Early in the 
follicular phase, small amounts of oestrogen are released stimulating release of LH and 
thereby stimulating more oestrogen production. By about the fourteenth day after onset of 
menstruation, oestrogen levels in the blood have increased approximately six-fold under 
the influence of FSH (Llewellyn-Jones, 1986).As both oestrogen and LH gradually 
increase they inhibit release of FSH and stimulate ovulation. Each stimulated follicle 
produces oestrogen for about one month. However, the corpus luteum (a temporary 
endocrine gland, which appears yellow) is formed in the mature or ruptured follicle, while 
the other follicles regress after ovulation. The Latin word for yellow is ‘luteus’ - hence 
luteinizing, or yellow-making hormone. The corpus luteum then produces progesterone, 
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the second main female sex hormone, which causes the lining of the uterus (endometrium) 
to thicken in preparation for pregnancy.  
 
Menstruation (menses) is the stage of the menstrual cycle when the endometrium is shed 
because fertilisation has not occurred (Martin, 1998). The rising levels of oestrogen reduce 
the level of FSH secreted by the pituitary. The blood vessels supplying the lining of the 
uterus deteriorate and breakdown causing bleeding and shedding of the uterine 
endometrium. The normal duration of discharge varies from three to seven days, but within 
weeks, the cycle has regenerated the endometrium in preparation to receive a fertilised 
ovum. 
 
Premenstruum is that part of the menstrual cycle immediately preceding menstruation 
(Martin, 1998). Premenstrual tension is a condition affecting some women for up to ten 
days before menstruation. It includes symptoms of nervousness, irritability, emotional 
disturbance, headache and sometimes, overt depression. The syndrome appears to be 
associated with the accumulation of salt and water in the tissues and generally disappears 
soon after menstruation begins. The hormone progesterone is thought to be a causative 
element (Martin, 1998) inducing the symptoms which include weight gain, abdominal 
bloating, cerebral oedema (contributing to memory loss, mood alterations and headaches) 
and premenstrual vocal fold oedema. The signs and symptoms of the premenstrual 
syndrome can be classified (Nader, 1991) as somatic (body states), affective (mood states), 
pain and behavioural states, such as food cravings, insomnia and fatigue. Other theories, 
including oestrogen withdrawal, aldosterone secretion and a relative deficiency in vitamin 
BB6 B have been proposed to explain the premenstrual tension syndrome. 
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The prevalence of reactions to pre-menstrual syndrome range from 30-40%, whilst severe 
symptoms probably occur in less than 10% of cases (Nader, 1991). This variation in 
reaction is due in part to the fluctuations of oestrogen and progesterone concentrations 
during the menstrual cycle resulting in differing symptoms and, in part, by the way in 
which individuals cope with the physiological changes at that time of month. The 
symptoms may be mild, moderate to intense whilst the cyclical nature and variation of 
symptomatology is individual (Nader, 1991). 
 
As the larynx is a hormonal target organ, with its morphology being affected by these two 
sex hormones (Amir & Biron-Shental, 2004), it is understandable that some singers are 
adversely affected by their changing body states. Some singers may be affected 
emotionally, whilst others manifest  physical aspects at laryngeal level,  i.e. a sizeable 
increase in the bulk of the cords will result in a lower pitch (Frable 1961), and yet others 
may find the bloating effect of fluid retention throughout the body affects their ability to 
support their voice effectively. Some singers are affected by the changes and some are not 
(Isenberger, Brown & Rothman, 1985). As a pedagogue of thirty years experience working 
with professional voice users, my knowledge of singers and their instruments support these 
facts and the huge variability of their symptoms and emotions.  
 
In summary, the complexity of the human female menstrual cycle affects all aspects of 
female physiology as well as women’s emotional well-being. The interaction of the 
hypothalamic, pituitary and gonadal hormones through their direct effects and their 
feedback control systems produce, in the majority of females, a regular series of events of 
a cyclical nature. Variations in symptoms and signs of these events are well documented 
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and the symptoms may affect the production of the voice and performance quality of some 
female professional singers. 
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1.4 Hormones and Vocal Quality 
 
U1.4.1 Introduction 
 
The female evolves physiologically from childhood under the influences of oestrogens, 
progesterone and testosterone. These hormones underpin the changes in a woman’s voice, 
which evolves throughout her life.  
 
Rubin (2001) stated that nothing is static about the larynx or the vocal tract. A 
characteristic element about each individual voice is timbre, which is hormone dependent. 
Voice changes in the general population are usually not of significant concern. However, 
for singers, any variation in vocal quality becomes a serious issue because their livelihood 
is affected directly by daily performance. Exacerbation of these changes occurs by the use 
of greater vocal range and power, which will expose the voice more readily to a wider 
range of difficulties and inadequacies. Singers are also more susceptible because of greater 
fine muscle usage and hence fatigue during vocalization, which can result in occupational 
vocal chord abuse. Such conditions require the facilitation of vocal changes (Chae, Choi, 
Choi, Jin & Kang, 2001) because any hard working singer, like any athlete, is susceptible 
to injury. 
 
Singers rely on their entire body to produce sound that is pleasing aesthetically and 
powerful enough to carry through a large auditorium and over an orchestra. For 
professional singers to excel, particularly operatic singers, physical mastery of respiratory 
control and strength is required.  Achievement of extensive pitch, range and flexibility also 
requires precise control. Singers are vocal athletes, who rely not only on physical strength 
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but who are dependent on skills of efficiency, coordination and precision (Harvey, 1997). 
Physical and vocal stamina, as well as a high level of fitness, are required to perform a 
lengthy recital or operatic role. This also requires experience and skill to sustain and 
monitor the necessary effort over a long period.  
 
By necessity and experience, singers are very aware of their bodies throughout 
performances and if the health of the body is disordered at any time, impairment of vocal 
function is a direct and immediate result (Bradley, 1980). Sensitivity to body function 
enables a singer to control unwanted effects of physiological changes. If not addressed, a 
negative effect on optimal vocal function, whether technical, emotional or physical, may 
limit the singer from realising her full potential as an artist. Consequently, they become 
aware of any slight variation in the quality or the quantity of the sound produced and are 
able to make adjustments to maximise their performance. Because any unpredictability of 
their instrument is a potential source of concern and frustration, maintaining good physical 
condition gives the singer the benefit of understanding and anticipating any change in 
vocal function or character. This is an essential skill for any young singer contemplating a 
career. 
 
Because a female singer’s instrument is her entire body and mind, any premenstrual 
changes affecting any organ system of the body may potentially affect her performance 
adversely. Known disorders may affect the larynx, eyes, respiratory function, energy 
levels, metabolism, appetite, weight control, nervous system, psyche and interpersonal 
relationships (Nix, 1998). Illness, injury or other numerous natural bodily processes may 
create vocal problems. The extreme complexity and interdependence of the glandular 
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system may produce a great variety of hormonal imbalances, which affect the voice 
(Brodnitz, 1971).  
 
Hormonal fluctuations are among the most common, unresearched and often perplexing 
causes of vocal dysfunction (Emerich, Hoover & Sataloff, 1996). Rubin (2001) found that 
in one study, 15.6% of 360 women treated for voice disturbances were suspected to have 
endocrinologic causes (Timonen, Sonninen & Wichmann, 1962, out of Rubin). 
Essentially, the larynx and the voice as an instrument, is extremely sensitive to endocrine 
changes. Hormone receptors for oestrogen, progesterone and androgen are present in the 
human vocal folds (Newman, Butler, Hammond & Gray, 2000) as detected by 
immunohistochemical staining. Depending upon the receptor type, their association varies 
significantly statistically by age and gender, as well as position within the nucleus or the 
cytoplasm of the cells. In 2003, a group of researchers (Altman, Haines, Vakkalanka, Keni, 
Kopp & Radosevich, 2003) determined that the human larynx also contains thyroid 
hormone receptors. These findings add significantly to the former theories of hormonal 
control of the voice in both genders, however, our understanding of the regulatory 
processes governing nuclear and cytoplasmic receptors is incomplete (Stein, 1998). 
 
Alterations in the bulk and shape of the vocal folds produce these changes, which result in 
perceptual and physical changes of the voice such as muffling, sluggishness, decreased 
range and loss of vocal efficiency and accuracy. If the findings of this study support the 
commonly held beliefs of the professional singing community, education and awareness 
about the influence of endocrine changes on the singing voice should become a high 
priority. For some singers, the cyclical nature of their negative vocal variation and 
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susceptibility, often assumed to be psychogenic or anxiety related, may indeed be related 
to underlying endocrine changes of the female hormonal cycle.   
 
U1.4.2  Puberty 
 
During puberty, there are major changes to the laryngeal anatomy because of the 
“hormonal earthquake” (Abitbol et al, 1999). Puberty is the onset of sexual maturity in the 
body and usually occurs between the ages of ten and eighteen depending upon the timing 
of the onset of menses (menarche). Before puberty, there is no progesterone production in 
the body (Abitbol et al, 1999). Increased secretion of oestrogen and cyclical production of 
progesterone create the vocal qualities associated with female voice, while an increase in 
testosterone is responsible for the vocal qualities associated with male voice. 
 
The female vocal folds grow from 1.5 to 4 millimetres, or thicken and elongate as much as 
34% (Rubin, 2001), while the male vocal folds grow between 4 and 11 millimetres, or 
thicken and elongate as much as 60% in length.. The length of the vocal folds determines 
the vocal character, because the female voice drops 2.5 semitones and averages a 
fundamental frequency of 220 to 225 Hz change when their voice change has been 
completed (Rubin, 2001). However, the male voice drops approximately one octave (13 
semitones) to a mean fundamental frequency of 130 Hz at age 18 to 20 (Rubin, 2001). On 
maturity, lower voice types in females and males have a longer larynx than that of their 
colleagues with higher pitched voices. Voice mutation occurs because of laryngeal growth 
(Sataloff, 2000) along with the changing angle of the thyroid cartilages in the male, and the 
length of vocal folds is related to final larynx size and the changes in the whole vocal tract.  
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Major vocal change is induced by this surge in hormones. The rapid acceleration in growth 
of the larynx results in frequent breaking and instability of the voice, particularly for males 
who are more affected, and often causes emotional discomfort. The vocal folds can also 
grow asymmetrically causing further vocal insecurity. It is not unusual for young boys to 
cease singing during his period. Young women may also be affected but the physical 
changes in the larynx are not as marked. Their vocal changes are often less obvious and 
they continue their singing during this period of change. 
 
U1.4.3 Pregnancy 
 
The voice changes in pregnancy have been called “laryngopathia gravidarum” (Sataloff et 
al, 1993). Any pregnant women who experiences loss of normal vocal facility during 
pregnancy, without physical damage to the apparatus, can be given an assurance that their 
dysphasia only occurs for the duration of the pregnancy. The hormones progesterone, 
oestrogen, human chorionic gonadotrophin (HCG) and human placental lactogen (HPL) 
are produced in the pregnant woman (Ganong, 1965). 
 
During pregnancy, professional singers commonly report changes in vocal quality. Imre 
(out of Brodnitz, 1971) examined two hundred pregnant women and found a high 
incidence of hoarseness and deepening of the voice. Any asymmetry caused by swelling of 
the folds may induce lack of control, loss of volume and lack of flexibility. Although such 
changes are usually temporary, vocalization during pregnancy should be approached with 
a degree of sensitivity and care because excessive strain may result in small bleeds within 
the vocal cords, called submucous haemorrhages (Imre, out of Brodnitz, 1971). It is 
important for singers to be aware of these potential problems so that excessive vocalization 
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through their professional workload can be reduced to avoid permanent damage to the 
vocal apparatus. 
 
On clinical examination, it was found that the vocal cords manifest redness, swelling and 
small submucous haemorrhages, which were more apparent than in non- pregnant females. 
Imre’s research (out of Brodnitz, 1971) revealed that these symptoms disappeared with 
cessation of the pregnant state. 
 
As pregnancy advances and a woman’s uterus expands, her abdominal support is 
progressively compromised. A professional singer relies on extremely strong and well-
coordinated abdominal musculature, which comprises the major groups of muscles such as 
internal and external obliques, latissimus dorsi and rectus abdominis. The thoracic muscles 
for breathing, internal and external oblique muscles are also affected by significant 
changes, as are the pelvic girdle muscles, which supply support to the abdomen. Any 
singer whose abdominal support is compromised substantially should be discouraged from 
singing until the abdominal disability is resolved (Sataloff et al, 1993). The fatigue of 
pregnancy also creates a negative effect on the voice because the physical stamina and 
strength as well as the abdominal coordination expected in the vocal professional may not 
be possible during this period.  
 
U1.4.4 Pre–Menstrual Syndrome (PMS) 
 
All women do not experience the premenstrual syndrome, and when evident is highly 
variable in symptomatology (Chae et al, 2001). Symptoms may vary from mild to severe, 
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as well as varying from cycle to cycle. In more severe cases, it can lead to disruption of 
general life style affecting occupational and social functioning.  
 
The syndrome continues to elude diagnosis with no theory being fully substantiated 
scientifically (Nader, 1991).  Although theories abound as to the reason for premenstrual 
symptoms, as yet there is no convincing evidence to support any of these possibilities as 
the definitive cause (Davis & Davis, 1993). It appears to be of primary concern in the 
literature, which continually seeks information regarding voice problems among trained 
singers during the menstrual cycle. The general body of all the literature surveyed 
continues to substantiate this through the many theories available.  
 
When the symptomatology involves a singer’s body and emotions, it becomes of serious 
concern to the performer. There appears to be a genetic factor or a familial predisposition 
to symptoms in women and in the general population about 25-50% of women report 
symptoms. However, there is no evidence of any correlation between race, culture, marital 
status or educational level and the symptomatology (Davis & Davis, 1993). Psychological, 
physical and vocal effects of premenstrual syndrome have a wide range of symptoms and 
individuals experience differences from cycle to cycle, probably because of factors such as 
personal stress levels, diet, health and age.  
 
Lacina (out of Chae et al, 2001) reported that many female singers had difficulties with 
intricate phonation control before each menstruation, deterring them from scheduling 
concerts whilst in the premenstrual phase. In this specific population, he noted that 75% 
experienced some physical change. “Singers notice changes in voice more readily than 
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non-singers, because they employ a greater voice range and also because occupational 
vocal cord abuse facilitates changes in vocal cords” (Chae et al, 2001).  
 
Shala Nader (1991) commented that the pathophysiology of the syndrome remains elusive, 
continuing to remain so throughout the collective literature, and as a result the treatment is 
essentially empirical. Her findings were that in the general population the prevalence is 
approximately 30-40%. Abitbol (Abitbol, de Brux, Millot, Masson, Mimoun, Pau & 
Abitbol, 1989) noted that in their study, 75% of female singers were affected and that 
female voice performers may experience special problems with vocalization during the 
premenstrual phase. Abitbol, et al (1989), Jurgen Wendler (1972), Brodnitz (1979), 
Lushinger (1965) and Perello (1962) all support similar conclusions, that there are acoustic 
and physiological changes to the voice just prior to and during the menses.  Brodnitz 
(1979) recommended avoidance of any unnecessary vocal strain during the menstrual 
period to prevent lasting damage to the voice. It has further been recommended that 
females whose career demands a higher degree of vocal efficiency should have regular 
physical examination of their vocal chords to maintain optimal vocal health and function. 
A sensitive support team of vocal teacher, accompanist, vocal coach and doctor, all aware 
and skilled in management of these presenting difficulties, should be an adjunct to a 
singer’s career, as premenstrual syndrome adds yet another dimension of anxiety to an 
already stressful life. 
 
Sataloff (1993) advises that singers with premenstrual syndrome should sing with a lighter 
mechanism than normal, should minimize their rehearsal times and avoid singing when 
their symptoms are most severe.  Awareness of such advice to reduce vocalization when a 
singer is most affected could possibly create more anxiety if a performance cannot be 
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rescheduled. Although the most severe symptoms occur around the last week of the cycle 
and can encroach upon the menses, it is probably quite impractical to schedule singing 
engagements around the menstrual calendar. During a significant period of the 20Pth P 
Century, female operatic singers in most of the major European opera houses were given 
“grace days” (where they were not required to sing) in recognition of the effect of 
hormonal changes on the singing voice (Sataloff, 1991)(Brodnitz, 1971). Financial 
constraints in professional companies in more recent times have resulted in changes to this 
policy, with a potential loss of income for the singer. 
 
According to Sataloff, “laryngopathia premenstrualis” is caused by physiological, 
anatomical and psychological alterations because of endocrine changes (Sataloff et al, 
1993). He notes that the common vocal symptoms associated with this premenstrual phase 
include a loss of high notes, vocal instability and fatigue, uncertainty of pitch, decreased 
vocal efficiency, reduced vocal power and flexibility, and huskiness.  He concludes that 
the physiological correlations to these perceived vocal changes are related to the drop in 
oestrogen levels on or about day twenty-one in the menstrual cycle. Smith-Frable (1961) 
comments on the vocal instability, vocal “breaks”, hoarseness, huskiness and a loss of 
vocal control, which Sataloff et al (1993) specifically call “laryngopathia premenstrualis”. 
Smith-Frable adds that pelvic discomfort, oedema, temporary weight gain, emotional 
outbursts, restlessness, irritability, breast tenderness and headaches are among the known 
symptoms of PMS. He continues that other factors affecting women are the feeling of 
social isolation and both decreased efficiency and motivation. A review by Silverman and 
Zimmer (1978) lists similar symptoms.  
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A diagnosis of premenstrual syndrome is only established if symptoms resolve for at least 
those days between the end of the menstrual period and ovulation, i.e. approximately days 
seven to fourteen of the cycle. Typically, symptoms are most severe during the 
“paramenstruum”, the interval that begins about the twenty-fourth day of the cycle and 
continues until approximately the fourth day of the menses (‘period’). Davis and Davis 
(1993) isolated four temporal patterns for the establishment of premenstrual syndrome. 
Firstly, the onset of signs and symptoms occur about two to ten days prior to the beginning 
of menstruation. These signs continue until the menstrual period begins or even into the 
first twenty-four hours of the period. Secondly, there are the onset of signs and symptoms 
at ovulation (about fourteen days prior to the onset of menstruation), which last for a few 
days, and are followed by some symptom-free days. The third temporal pattern is the onset 
of signs and symptoms at ovulation, which continue uninterrupted until the beginning 
menstruation or even into the first 24 hours of the period. Finally, there are the onset of 
signs and symptoms at ovulation, which continue through to nearly the end of the 
menstrual period and these women complain that they “have only one good week a 
month”.  
 
Abitbol et al (out of Emerich et al, 1996) agrees that the alteration in oestrogen levels 
cause laryngeal water retention, oedema of interstitial tissues and venous dilatation. The 
laryngeal tissues begin to absorb water as the oestrogen levels begin to drop, which in turn 
causes vocal fold swelling with engorged blood vessels and increased vocal fold mass.  
The small blood vessels supplying the vocal chords become more “leaky” causing fluid to 
accumulate in the chords. Concomitantly, polysaccharides break down into smaller 
molecules in the vocal chords, bind water more readily and lead to greater fluid retention. 
Consequently, the vocal chords swell with fluid causing the vocal symptoms described. 
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The changing ratio of oestrogen to progesterone results in fluid retention and asymmetry of 
the vocal folds, which can be visualized by videostroboscopy.  
  
Lushinger and Arnold (1965), out of Wilson and Purvis (1980), stated that upon 
observation of the vocal folds, just prior to and during menstruation, it revealed that they 
were swollen and oedematous with quite a marked reduction in mucous secretion. This 
could give the singer a feeling of dryness and hoarseness. Abitbol et al (1999) noted that 
dynamic vocal exploration by televideo-endoscopy showed congestion, microvarices, and 
oedema of the posterior third of the vocal folds with a loss of vibratory amplitude. 
Brodnitz (1971), in a case report from the same review, indicated similar negative effects 
of menstruation on a professional singer’s voice. Wendler (1972) (out of Rubin, 2001), in 
an acoustic and physiological study of thirty females, reported a reduction in vocal 
efficiency during the premenstrual and menstrual periods.  
 
In the 1890’s, Bayer and Oppenheim (out of Davis & Davis, 1993) reported menstrual 
related hoarseness, laryngeal haemorrhage and tracheal disorders. Since that time, other 
studies have shown vocal fold oedema and congestion, laryngeal joint stiffness and even 
instances of complete aphonia (Smith-Frable, 1961; Abitbol et al, 1989). These physical 
changes inevitably cause problems related to pitch, volume, quality of sound and the 
flexibility of the instrument. General physical attributes such as endurance and vitality, and 
vocal characteristics of pitch stability and voice quality, are altered by premenstrual fatigue 
because the larynx is especially sensitive and vulnerable. Good vocal production requires 
good physical condition and integrated control of physical and mental processes. 
Abdominal muscle tone and respiratory endurance, upon which the singing voice depends, 
are impaired when a singer is fatigued. Consequently, the singer will attempt to 
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compensate for lack of strength and coordination by instinctively using inappropriate 
muscle groups to support the tone, such as the accessory neck muscles. This secondary, 
uncoordinated and unsupported vocalization results in a forced tone and has the potential 
to initiate vocal damage such as a small vocal chord haematoma. Educating singers about 
the correct management of their premenstrual syndrome requires a more sophisticated 
approach.  
 
Abramson et al (out of Emerich et al, 1996) agrees with such observations by adding that 
altered metabolic activity by oestrogen sensitive cells could have an effect on the quality 
of the voice. Vocally, it can present several symptoms such as breathiness, ‘breaks’ in 
phonation, a loss of the high notes in the range and fatigue. Brodnitz (1971) adds 
huskiness and a lowering of pitch to the symptomatology. Change in the overall size and 
mass of the vocal folds results in changes to the vibratory characteristics of the chords, 
which is a serious consequence for any professional singer. Wicklund (1996) stated that 
swelling of the vocal folds have been confirmed by acoustic measures of vocal range and 
quality. In addition, otolaryngologists have reported cases of alterations in the appearance 
of the vocal folds of singers just prior to the onset of menstruation, specifically vascular 
changes and increased oedema (Higgins & Saxman, 1989). These statements are supported 
by Weiss (1988), (out of Emerich et al, 1996), who commented, “when a woman 
experiences lower oestrogen levels, she performs poorly on complex motor tasks, 
including phonation”. Chae et al (2001) confirmed that the vocal chords are hormonal 
target organs and that singers report anecdotally distressing vocal alteration during the 
several days preceding the menses. Such issues of reduced beauty and efficiency of sound 
are very serious for the professional artist. 
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In 1968, Lacina reported that the changes to the voice appear proportional to the presenting 
severity of the premenstrual symptoms and added that it is unquestionable that vocal strain 
during the menstrual period leads to premature deterioration of the voice and impairment 
of vocal quality. Lushinger (out of Silverman & Zimmer, 1978) agrees that “nothing can 
be more obvious than that a female singer needs rest during the days of her cycle”. Smith-
Frable (1961) stated that the vocal changes preceding menses are unrecognized symptoms 
of premenstrual tension. Because the incidence in the general population of voice change 
is 20-50%, intricate changes in voice are obviously present in many women with no voice 
training, which supports the views of Smith-Frable.  
 
Despite the growing evidence of physical symptoms for singers during this period, the 
effect of the menstrual cycle on voice continues to be an area of much debate and 
investigation (Chae et al, 2001). More recently, Chernobelsky (2002) studied fifteen 
healthy female classical singers, final year students of music college, and fifteen vocally 
abusive female classical singers, first year at music college. He found that premenstrual 
hyper-changes (hyperaemia and oedema of the vocal folds) were a result of combined 
abuse- and menses-related influence on the larynx, and further that, abuse- and menses-
related changes of the larynx appear very similar although resulting from different causes. 
Problems with a less well-developed vocal technique are increased with vocal use and 
decrease with rest. Hormone related effects might be compounded in vocally abusive 
singers who use their voice around menses, constituting a high-risk group for the 
development of vocal nodules (Chernobelsky, 2002).  
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U1.4.5  The Oral Contraceptive Pill 
 
Most contraceptive pills are a combination of synthetic oestrogen and progesterone. The 
aim is either to maintain a consistent level of both of these hormones throughout the cycle 
or to emulate the menstrual cycle by varying the proportions of the hormones, but 
essentially to prevent ovulation, and thereby, pregnancy. Because there is no conclusive 
evidence to date of a connection with taking the pill and negative vocal effects, 
professional singers cannot yet be certain that their fears in this regard are justified (Boulet 
& Oddens, 1996). 
 
During the 1960s and the 1970s, some concern was expressed in a number of reports that 
stated that there appeared to be some virilization in the voices of women using oral 
contraception. The relatively high progesterone content of some pills is most likely to 
produce androgen-like changes while oestrogen has no known negative effect on the 
female voice (Sataloff, 1995). Sataloff also expresses concern regarding the number of 
hormone preparations containing a small amount of testosterone.  More recently, 
contraceptive pills use lower levels of both oestrogen and progesterone making virilization 
of sound less likely. 
 
Female singers use the contraceptive pill relatively infrequently because of the perceived 
changes that the medication may have on their instrument. Range or quality of sound may 
be affected negatively after a relatively short time of using the oral medication. There has 
been anecdotal evidence about the possible negative effects, which may include a loss of 
high notes, but there has been no scientific evidence to support this (Comins, 2002). 
However, it appears that these changes are reversible upon ceasing the medication.  
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The two synthetic hormones, oestrogen and progesterone, have a negative affect on the 
voice in only 5% of women (Boulet & Oddens, 1996). However, singers are 
understandably cautious about ingesting anything that may affect the function or tone 
quality of their voice. It was reported by the same researchers that 29% of women found 
changes to their voice whilst taking the pill, for which they were unable to find either 
physical or vocal reason.  
 
Women who suffer severe symptoms on a cyclical basis find that the pill appears to 
balance the unevenness of hormone levels and that this is a very positive aspect. In turn, 
this results in more even vocalization over the entire cycle, because the drug provides them 
with the same amount of oestrogen and progesterone throughout the cycle (Ledger et al, 
out of Comins, 2002). The same study hypothesised that hormonal consistency of the 
singer on the pill may be of benefit because water retention in the tissues may be reduced 
and vocally this would be highly preferable. Consequently, the steady state of hormones in 
the pill would limit any vocal changes because of oedema, including any asymmetry of the 
vocal folds, and the effects would probably be less evident to both the singer and the 
audience. 
 
The oral contraceptive pill is convenient and reliable in avoiding pregnancy. In the United 
States, the estimate is that 30% women use the contraceptive pill (Rubin, 2001). However, 
women on the pill may experience less vocal change because of the stabilisation of their 
hormones. When it is evident to the singer and the vocal teacher that there are extreme 
imbalances in the hormonal levels, the pill may be considered as a means of stabilising the 
hormonal changes and hence the voice (Brown et al, 1982). 
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Studies that are more recent (this thesis commenced in 2002) tend to negate a lot of the 
anecdotal evidence and papers included in the original literature search. It is not yet clear 
from the present studies whether the current, modified hormonal balance in women on the 
pill affects vocal quality any differently from the “natural” hormonal cycle (Amir et al, 
2002). Amir et al, in papers published in 2003 and 2004, went on to suggest that results for 
singers taking oral contraceptive medication (low-dose monophasic preparations) do not 
show an adverse effect on the voice. In fact, Amir, Kishon-Rabin and Muchnik (2003) 
suggested that voice stability is associated with the smaller hormonal fluctuations induced 
by the contraceptive pill. However, they also stated that because the volunteers were 
students, in a comparative study between those taking the medication and those not taking 
it, “these results cannot be readily applied to professional singers”. They went on to say 
that, voice quality among pill users was typically better than that of the control subjects 
(Amir et al, 2004). 
 
In conclusion, if a singer decides to use the oral contraceptive pill, careful monitoring of its 
effects and/or side effects might be advisable initially, especially listening for obvious 
voice changes. She can also take advice from a medical practitioner in tailoring the 
hormone content, thereby ingesting the smallest doses available to ensure protection from 
pregnancy and a safe level of hormone for the voice. 
 
U1.4.6 Menopause 
 
Generally, the menopause or ‘climacteric’ occurs in women between the ages of 45–55 
years. During this time, fertility gradually declines with the loss of ovarian function and 
the loss of trophic actions of oestrogens, and secondary symptoms such as vasomotor 
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dysfunction, hot flushes, night sweats and sleep disorders may occur in some women 
(Emerich, Hoover, Sataloff, 1996). The constellation of symptoms can begin up to five 
years prior to the climacteric and can include emotional and psychological changes, such 
as depression, mood swings, irritability and lack of self-confidence. 
 
This most prominent hormonal change is in fact a ten to twenty fold drop in oestradiol 
levels while there is a relative increase in circulatory progesterone and androgen (Khaw 
1992, out of Sataloff). The ovaries gradually reduce their production of oestrogen to 
almost zero. The menstrual periods become irregular and may vary in quantity as 
progesterone production is reduced. Finally, with the complete cessation of cyclical 
bleeding, the secretions from the ovaries change with further reduction of oestrogen 
leaving the remaining androgens freer to act. In opposition to oestrogen, these small 
amounts of androgens cause thickening of the glandular secretions of cervical mucosa and 
drying out of the seromucous glands throughout the body. 
 
Because the ovaries have stopped producing oestrogen, masculinization of the voice 
occurs and can vary from individual to individual depending on each woman’s hormone 
profile and percentage body fat. Further, decrease in oestrogen causes vocal fold oedema 
with subsequent increase in swelling of the vocal folds and vocal fold thickening (Abitbol 
et al, 1989). Because this results in an increase in the mass of the vocal folds, there may be 
a resultant change in the characteristics of the vocal folds, which alters the quality of the 
sound (Emerich et al, 1996). Boulet and Oddens (1996, out of Rubin) state that the loss of 
oestrogen resulted in problems of voice emission because of changes to the vocal folds 
causing a loss of suppleness. This is especially noted by people most sensitive to the 
quality of their voice for their livelihood, such as singers, actors, ministers of religion, the 
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legal profession and schoolteachers. Voice professionals feel as if this hormonal 
disturbance has a negative effect on their vocal career and emotional lives. The findings of 
spectrographic analysis confirm that certain harmonics of the voice are lost (Abitbol, 
Abitbol, Abitbol, 1999) and show a thirty-percent reduction in the calling voice, the 
projected voice and the singing voice as well as revealing that there was a feeling of 
flatness of tone and loss of colour.  
 
Loss of timbre, brilliance, colour, flexibility, volume, upper notes and vocal fatigue have 
been reported (Harris, 1992; Nadoleczny, 1926; out of Rubin, 2001). Singers have also 
noted such symptoms as a lowering of vocal intensity, vocal fatigue, decreased range with 
a loss of the high notes and a loss of timbre in the spoken and singing voice (Abitbol et al, 
1999). For the professional singer, this is evident in poor performance of some of the 
complex motor tasks involved in singing, including loss of high notes, fatigue, instability 
of sound, uncertainty of pitch, decreased vocal efficiency, huskiness and reduced power 
and flexibility (Emerich et al, 1996). 
 
The vocal muscles are also affected because of androgenic effects on voluntary (striated) 
muscle movement. There are also a number of other age-related physiologic symptoms 
including a general decrease in lung power, atrophy of the laryngeal muscles with 
stiffening of the laryngeal cartilages and loss of the elastic and collagen fibres (Emerich et 
al, 1996). There is reduced hydration of the free edges of the vocal folds and any dryness 
during phonation leads to rapid vocal fatigue and to decreased ease of phonation (Abitbol 
et al, 1999). These symptoms are exacerbated if a singer practises their vocal exercise 
program infrequently. 
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Both sexes undergo changes at about 50 years of age, although problems with emission of 
the voice control of the instrument and attainment of the highest registers seems to occur 
more typically in female singers than in male singers (Boulet & Oddens, 1993). This same 
study stated that 65% of women believed that these vocal changes were related to 
menopause. These changes are progressive and slow vocal deterioration is first noticed in 
the high notes and in pianissimos (passages sung as softly as possible). Singers also report 
some loss of speed in staccato, loss of range, loss of intensity and loss of formants in the 
high notes. Boulet & Oddens (1993) stated that there is anecdotal evidence of professional 
singers who experienced loss of brilliance and power, as well as decreased ability to reach 
high notes during the climacteric and after the menopause. The voice problems reported by 
male singers related to similar phenomena (Boulet & Oddens, 1996) the complaints being 
hoarseness, a duller voice, increased vocal fragility/sensitivity and problems in transition 
from the middle to the higher registers; this was after elimination of those male singers 
whose voice symptoms could be attributed to disease states. 
 
There is some consistency of symptoms between menopause and the premenstrual 
syndrome, because the hormonal changes are similar at both times. Coincidentally, there is 
also a striking histological resemblance between smears taken of the cervix and those of 
the vocal folds (Abitbol et al, 1989). Not surprisingly, oestrogen target cells were found in 
the larynx in the late 1980s and more recently (Chernobelsky, 1998), while Newman et al 
(2000) demonstrated progesterone and androgen receptors in the vocal folds and Altman et 
al (2003) demonstrated thyroid hormone receptors in the human larynx.  
 
Both the premenstrual phase and menopause result in a drop in oestrogen and Sataloff 
(2001) states that the changes in voice occur because of the decrease in oestrogens and the 
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relative increase in androgens. Sataloff (1996) recommends that, rather than abandon their 
singing careers, singers should use hormone replacement therapy (HRT) to reverse these 
changes, because oestrogen has an organ preserving effect on the larynx. Lindholm et al 
(1997) concluded that at least the early postmenopausal years are associated with vocal 
changes and that HRT counteracts this phenomenon. With the maintenance of appropriate 
hormone levels, consistent vocal training, and physical exercise, women should be able to 
continue to sing well into their sixties and seventies. Abitbol (1999) noted that the 
improvement in sound was marked after four to six months of HRT.  
 
The type of medication for professional singers should always be cautiously chosen. 
Emerich et al (1997, out of Rubin) noted that singers on combined (oestrogen and 
progesterone) hormone replacement did not respond as well as those only on oestrogen. 
They cautioned that while testosterone will not usually affect the voice, a number of 
hormone replacement medications contain small amounts of testosterone. These 
researchers advised that the dose of HRT should be minimised and adjusted according to 
serum oestrogen levels, with close medical follow-up for vocalists.  
 
While most women will show tolerance to androgens, a significant number of women 
notice changes in their voices because of androgens. Androgens may produce permanent 
lowering of the fundamental frequencies, especially in females, and coarsening of the 
voice (Sataloff, 1995). However, Damste (out of Emerich et al, 1996) recommended that 
under no circumstances should androgens be given to female singers, even in small 
amounts, (if there is any reasonable therapeutic alternative) as they cause irreversible 
unsteadiness in the voice, rapid changes of timbre, and lowering of the fundamental 
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frequency. Therefore, singers need to be well informed about the intrinsic danger of 
androgen use and its potential to masculinize the voice. 
 
Sataloff (1991) also reported that conjugated oestrogens (salts or esters of equine oestrone) 
may be preferable to oestradiol, whilst Lindholm et al (1997) stated that at least the early 
postmenopausal years are associated with vocal changes and that HRT counteracts this 
phenomenon. They went on to confirm that HRT action seems to be more pronounced with 
oestrogen than with a combination of oestrogen and progestin. Sataloff (1995) suggested 
that the baseline oestrogen levels of professional singers should be obtained at around 
thirty-five, so that at menopause declining oestrogen levels can be readily recognised and 
rectified. He stated that participation in this practice would allow endocrinologists or 
gynaecologists to tailor hormonal replacement therapy to the patient’s past individual 
hormone profile. Oestrogen replacement is helpful in prevention of the typical voice 
changes that can follow menopause and professional voice users who are concerned about 
safeguarding their current vocal profile should be offered HRT at the time of menopause. 
This, of course, would need to be under medical supervision appropriate to the individual 
vocalist and the doctor would need to take into account any relevant contraindications. 
 
U1.4.7  Other Endocrine Medications 
 
There are other endocrine medications that may beneficially affect the voice. However, 
medications used to treat disorders in any part of the diencephalic-pituitary-axis should be 
monitored closely for possible changes in vocal function because of their potential 
laryngeal effects. Brodnitz (1971) warns that the steadily increasing use of therapeutic 
hormones, and of hormone related drugs, has sharply increased the potential incidence of 
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iatrogenic disorders of the voice. He stated that 14.1% of voice disorders could be traced to 
some endocrine cause, whilst 15% of disorders are caused by hormone-related drugs.  
With hormonal imbalances (pregnancy) or deficiency states (thyroid deficiency) Brodnitz 
warned that changes in pitch and quality occur frequently. Examples include the hormone 
treatments that have been used in the management of endometriosis (androgens), 
fibrocystic breast disease (progesterone), menstrual dysfunction (oral contraceptive pill) 
and hormonal imbalance (Pattie, Murdoch, Theodoros & Forbes, 1998, out of Rubin 
2001). The tremendous complexity and interdependence of the various glandular systems 
can potentially produce a great diversity of hormonal imbalances, which in turn may affect 
the voice. 
 
The medical profession, who may well be unaware of potential dangers to the voice, use 
anabolic steroids (e.g. corticosteroids) widely in such illnesses as chronic arthritis, renal 
failure, breast cancer and osteoporosis. Whenever synthetic derivatives of testosterone are 
incorporated into hormonal treatments for women, such as the oral contraceptive pill, the 
potential of androgenic side effects on the voice is of significant concern. Brodnitz 
suggests that vocal disorders may be the first clue to the fact that there is a possible 
diagnosis of endocrine imbalance or deficiency. The unsteadiness of voice, lack of vocal 
quality control and a lowering of pitch are serious (Sataloff, 1995) effects on the singing 
voice. 
 
The adverse effects of androgens include permanent lowering of fundamental frequencies 
and coarsening of the voice, characterised by a sharp lowering of basic pitch to a 
masculine level, general roughness in quality, cracking or breaks in the vocal range and 
discernible difficulty in controlling the instrument during speech and singing. Virilization 
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of the voice is not a reversible situation and cessation of the medication has no effect. 
However, not all women are affected, and it is not possible to determine beforehand those 
who will react unfavourably. Singers need to be aware that it is essential to cease 
medication at any hint of hoarseness or any other change of voice (Brodnitz, 1971). 
 
Thyroid deficiency results in a rough, hoarse sound with limitation of the upper vocal 
range, general vocal fatigue and often a feeling of a lump in the throat. Thyroid 
replacement may restore vocal efficiency but the “ring” is lost with even a mild degree of 
hypothyroidism (Sataloff et al, 1993). Altman et al (2003) demonstrated that thyroid 
hormone receptors are present in the human larynx, suggesting a potential role of thyroid 
hormone in normal laryngeal development, physiology and function. The anxious, sweaty, 
nauseous professional singer with prominent eyes and an overactive thyroid (Sataloff, 
1994) will have adverse effects on the voice also.  
 
Insulin imbalances such as diabetes mellitus may also cause a dry voice (Comins, 2002). 
Anecdotal personal communications from female singing students suggest that both low 
blood sugar levels (hypoglycaemia) and poor levels of hydration (inadequate fluid intake) 
affect the voice in a negative manner, making vocalization more difficult through lack of 
physical energy and concentration.  
 
Virtually all medications have some laryngeal effect (Sataloff, 1995). Hormone 
imbalances affect voice. Hormone therapies restore voice (Sataloff, 1994). 
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1.5  Hormones and Emotion 
 
Frank (1931) introduced the term “premenstrual tension”, to describe “a relationship 
between hormonal changes during the menstrual cycle and recurring psychological 
manifestations such as depression or irritability. These symptoms may vary monthly in 
incidence, number, and intensity among the affected and a given individual may 
experience marked variation from cycle to cycle because of factors such as stress, diet, age 
and general health.” 
 
Laryngologists, voice specialists and professional singers all recognize that one’s mental 
state can affect vocal performance and that there can be several causative factors to this 
mental state. When altered emotions are part of cyclical change in the premenstrual period 
(premenstrual tension syndrome), then the affected performer may find that the 
development of their professional career is considerably and consistently altered. Many 
vocalists may be aware of change in their voice around that time, because the professional 
singer is so perceptive to the slightest change in their instrument, but may not be aware 
that those same changes are the result of bodily function and cannot be managed easily. 
The lack of predictability and variable nature of the symptoms, as well as the variable 
intensity of the outcome, may result in difficulties of diagnosis and management. 
 
The human voice is a complex, daily changing instrument and the premenstrual tension 
syndrome can add unnecessary anxiety to the already demanding life of a performing 
artist. Understanding the symptoms and familiarity with their effect can placate the 
disappointment in a performance that is not of the ideal or expected standard. This 
inconsistent change causes dissatisfaction to the professional singer who constantly 
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attempts to adapt to the variation. Whilst the experienced singer can often control 
performance nerves in a positive way, she must also learn to deal with the physical 
symptoms of pre-menstrual tension, if her livelihood is not going to be affected adversely. 
During premenstruum, the female singer is still expected to display the same level of 
professionalism and courtesy toward her peers. However, if she is feeling unusually 
susceptible to criticism from her fellow performers, conductors and directors, as well as 
being in a highly emotionally charged state, then her professionalism may be undermined. 
Such singers may react inappropriately with anger and hostility acquiring a reputation for 
being difficult, unreliable, uncooperative and volatile. Consequently, if it affects them on a 
cyclical basis, their reputation and ultimately their career will be compromised. In the 
highly competitive world of the opera singer, such behaviour is undesirable. 
 
The wide assortment of psychological, neurological and interpersonal aspects of 
premenstrual symptoms includes tension, loneliness, morbid or pessimistic thoughts and 
paranoia. Chae et al (2001) noted sadness, tension, anxiety or conflict with other 
individuals, plus withdrawal from social activities. Brown and Hollien (1982) noted that 
depression occurs just prior to and during the first days of menses. Abitbol et al (1989) 
stated that nervousness, irritability and depression characterized the presence of 
premenstrual tension. Smith-Frable (1961) noted that the symptoms included unreasonable 
emotional outbursts, restlessness and irritability. Davis and Davis (1993) noted that 
behavioural changes may be variable in incidence each month. Any given individual may 
experience variation of symptoms from cycle to cycle because of such unpredictable 
factors as stress, their general health, diet and age. 
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Premenstrual tension syndrome is not regarded as a psychiatric disorder because it does 
not meet the criteria for such a diagnosis. Firstly, many of the symptoms, which are related 
to the luteal phase of the menstrual cycle, are physical rather than emotional in origin. 
Secondly, it is a disorder that is not permanent, and subjects respond within the normal 
range to psychological evaluation. Some law schools make their students aware that 
premenstrual tension syndrome can be utilized as a legal defence for temporary insanity in 
cases of manslaughter, personal injury, arson, assault, child abuse and marital strife. A few 
insurance companies now reimburse for the cost of treatment for premenstrual syndrome 
(Davis & Davis, 1993). 
 
Electroencephalogram (EEG) changes have been noted during the premenstrual phase of 
the cycle. Mood changes, loss of memory and headaches could all be related to fluid 
retention and brain swelling. Similarly, a number of major PMS symptoms, including 
anxiety, irritability, depression, and abdominal cramping, may be regarded as dysfunction 
of the central nervous system (CNS). This suggests that hormone level variations during 
the menstrual cycle have effects on brain chemistry (Davis & Davis, 1993). 
 
The voice is also an exquisite messenger of emotion (Sataloff, 1997). Over many years of 
experience, highly skilled singers learn how to adjust their mood states and control the 
anxiety associated with performance. However, the more challenging aspect is the 
uncertain factors caused by symptoms of premenstrual tension syndrome. Profound 
emotional disorders have long been known to contribute to the functional losses of 
audition, phonation and other performances of speech. Less severe neurologically induced 
symptoms such as muscle tension and rapid heart rate that affect a performing artist may 
manifest prior to performance as “pre-performance nerves”. Whatever the source of 
 45 
muscle tension, nervousness or loss of control of emotions, these symptoms can cause 
major disruption to a singer’s technique, especially when they are sensitive to minute vocal 
changes. 
 
Physiologically, the heightened emotional state may be expressed by shouting and/or 
crying which increases pressure on the vocal apparatus. Along with difficulty in sleeping, 
and muscular tension, manifest in tightness of the shoulders, chest, jaw and neck, difficulty 
in phonation may become apparent as the muscles work against each other. This further 
adds to the frustration, anxiety and tension to an already stressed singer who becomes 
more confused and frustrated that her voice is not functioning in the best possible 
condition.  
 
Potentially this sets up a vicious circle, which becomes more difficult to control with time. 
Confidence in one’s performance, which a singer has worked for so many years to achieve, 
can easily fall prey to hypersensitivity to criticism, uncertainties, irritability, despair, and 
consequently, further self-criticism. These feelings can severely limit a career in that the 
symptoms could make a singer question their career choice and negatively destabilise their 
motivation to practice and improve their skills. 
 
In order to survive in the highly competitive world of professional singing, singers must 
have a very positive sense of self-worth, strength of mind, and absolute self-assurance in 
their own special talent and future. Any negative thoughts can disarm the singer of the 
energy and confidence necessary to continue. The resulting self-doubts will be 
exasperating for supporters such as singing teachers, coaches, directors and conductors and 
are likely to result in a decrease of enthusiasm necessary for that particular artist.  
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It is essential for a singer’s well-being to gain the key knowledge about such symptoms, 
which can have a devastating effect on their individual performances and their whole 
career, as an awareness can result in assistance, support and understanding from 
professional colleagues and supporting allied personnel. Difficulties would manifest 
themselves in the weekly exposure to singing lessons and rehearsals as well as in the work 
and home environments. The singing teacher, with major input into the career, could 
become disillusioned and perturbed that someone of such obvious talent with excellent 
career prospects could be so uncooperative, crushed and unfocused on a regular or cyclical 
basis. The relationship between the two is then spoiled, as any new technique or 
interpretative ideas and career suggestions will not be received in an atmosphere of 
collaboration and interest. Throughout this process, the singer may be totally unaware of 
these cyclical emotional changes unless they have gained knowledge of the hormonal 
effects on the singing voice. 
 
It is more than likely that many a talented singer has experienced emotional aspects of the 
pre-menstrual syndrome and its effect on their inter-personal relations. Such symptoms 
usually begin prior to menarche and would continue through to menopause, often 
becoming more intense with age. Premenstrual tension could arguably affect an individual 
singer’s professional and personal relationships, and the success of her career (Davis & 
Davis, 1993). 
 
The recognition of such florid effects of premenstrual symptoms by the teacher would be 
almost essential, if progress is being delayed or sporadic. A referral to a physician, more 
especially an endocrinologist, for assistance would be most beneficial along with 
emotional support from a designated support group rather than just by colleagues. By 
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understanding of the symptoms and admitting that there is a problem the singer, with 
medical support to reduce or alleviate the cyclical nature of the symptoms (Nader 1991) 
may find confidence and the emotional strength to achieve the vocal, personal and 
professional potential that is evident in her work. 
 
Allaying the fears and anxieties along with understanding, support and explanation are 
essential aspects in management of these problems. Awareness of other family members 
with these symptoms may help to create better awareness and greater acceptance of the 
consequences, because a genetic element appears to exist with the premenstrual tension 
syndrome.  The significant degree of psychological trauma that may exist is deserving of 
sympathetic handling particularly when the career aspirations may have been so 
significantly affected (Davis & Davis, 1993).  
 
Medication such as tranquillisers and sedatives are rarely necessary and essentially 
undesirable because of the interference with fine motor control and the potential to 
frustrate a singer further, who finds the instrument difficult enough to handle at such times. 
 
It is essential for singers to become better educated and aware of the large range of body 
changes that can occur, so that they are able to adjust to the challenges. Sataloff (2002) 
stated that singers are trained to discern subtle differences in the supernormal to near-
perfect range in which the professional performer’s body must operate. According to 
Lusingher, in marked premenstrual tension, physical, intellectual and emotional 
performance is reduced through the discomfort experienced during these days. 
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Arranging singing engagements around the menstrual cycle may assist the performer. 
However, variability in the menstrual clock due to various circumstances such as illness, 
stress or menstrual synchrony with family or associates, needs to be noted. 
 
The skilled singer can utilize pre-performance anxiety in a generally positive manner to 
enhance the level of excitement in the performance. However, pre-menopausal physical 
changes, which cannot be controlled or utilised constructively may cause a singer to feel 
that her instrument is not in its usual condition. This can severely undermine her level of 
confidence and control.  
 
1.6 Aims of the Study  
 
Professional singers are expected to present on stage with a consistency of range, even, 
clear and beautiful vocal quality and the same reliability in every performance, to project 
above the volume of the orchestra. Any unpredictability in their instrument is a source of 
anxiety and frustration, while controlling any variable is of paramount importance. 
 
Brodnitz (1979) noted that singers notice even minor impairments of vocal function. 
Professional survival in an ever increasingly competitive market is dependent on a singer’s 
ability to produce beauty and consistency of the highest standard. Professional singers 
must track the source of any variation and be in a position technically, musically and 
emotionally to combat any change and bring the instrument back under control. An 
inability to achieve a consistency of the highest standard could well limit their potential as 
an artist. In turn, this can negatively affect self-esteem, potential income and prestige 
among their professional colleagues. 
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Clearly, from the studies and empirical reviews to date, pre-menstrual syndrome 
negatively affects many singers. Interest in the effect of menstruation has appeared in the 
literature for more than forty years. Smith-Frable (1962) concluded that hoarseness was a 
recognised symptom of premenstrual syndrome, while Sataloff (1993) stated that 
professional voice users needed to become educated about the influences of endocrine 
changes on the voice. Lacina (1968), of the National Theatre in Prague, wrote that 
menstrual dysphonia affected one-third of the female singers in that opera house. European 
opera houses typically excused singers from singing during the premenstrual and early 
menstrual days, the so-called “grace days” (Sataloff, 1996). 
 
Because the singer’s body is their entire instrument, it is of paramount importance for them 
to be sensitive to and understand their physical condition. Vocal professionals are curious 
to discover the basis for any vocal problems. Any changes which have a negative effect on 
their sound is part of the knowledge a professional singer must possess. Without such 
knowledge, a singer’s stressful life as a performer will have added and unnecessary 
anxiety. An instrument maintained at optimal function and beauty gives the singer 
confidence and relaxed phonation. 
 
Nix (1998) commented that it would not be possible to schedule singing engagements, 
lessons, rehearsals, competitions, auditions, and examinations around a singer’s menstrual 
calendar; learning to recognize, prepare and manage symptoms becomes the only solution 
that is viable. Chae et al (1997) recommend that singers deter from scheduling concerts 
while in the premenstrual phase. 
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The available literature presents variable results and reviews on the seriousness of this 
problem. However, professional singers commonly complain of vocal fatigue, loss of 
range, changes in vocal quality and other factors several days each month during which 
certain physiological changes prevent the normal use of the larynx. According to past 
studies, for some singers these changes are minor, but for others the situation has 
repercussions that are more serious. 
 
I have noted that there are several inconsistencies in recording of symptoms in the 
literature to date. This is due, in part, to the range of females chosen, i.e. professional 
singers and non-singers, and the wide range of age groups, including some menopausal 
subjects. The methodology is also open to scrutiny because the vocal testing ranged from 
spoken vowels or sustained tones through to singing a nursery rhyme. The testing of 
vocalization in this manner hardly supports or challenges the results from the literature 
which state that premenstrual tension gives singers hoarse voice and vocal fatigue 
(Wicklund, 1996), a drop in volume and quality (Abitbol et al, 1999), and breathiness 
(Isenberger & Brown 1982). The testing methodology does not challenge range, control or 
quality of sound, and studies of this kind have little relevance for a professional voice user. 
 
Brodnitz (1979), having requested phonated vowels rather than sung tones, has not taken 
into account the substantial demands on a singer’s voice and body, as well as the high 
quality of expected performance every day of their working lives. The type of sample 
taken must challenge the already known body of knowledge about vocal symptoms to be 
able to inform artists accurately of the extent of variation caused by the premenstrual 
syndrome.  
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It is not relevant to professional singers to give results of sound quality from untrained 
non-singers {three studies (Chae, et al, 1997), (Isenberger & Brown, 1982) and (Higgins & 
Saxman, 1989)}. Professional singers and full-time singers in professional training deserve 
far more accurate and sensitive information. 
 
Wicklund (1996) used a range of women up to the age of fifty-seven. Sataloff (1996) states 
that menopause occurs in women from their late forties to their early fifties as fertility 
declines with loss of ovarian function. An accurate symptomatology of pre-menstrual 
syndrome is inaccurate if a number of subjects are pre-menopausal. The significant loss of 
oestrogen in menopause results in vocal change, but this is different to the premenstrual 
syndrome where there is fluctuation of hormone levels, despite that fact that both 
conditions are similar in that there is a decline in oestrogen with a relative rise in 
progesterone. 
 
An alternate concern is that in several studies, research subjects were taking oral 
contraceptive medication. As it is known that these hormones reduce the larger hormonal 
fluctuations of the natural menstrual cycle (Isenberger, 1982) this would again create fewer 
variables in the results. Singers taking the oral contraceptive pill demonstrated 
significantly smaller variance for all variables tested (Amir, et al, 2002). 
 
In the studies to date, there have been a number of methodologies employed. However, 
none has used audiotapes evaluated by the singers themselves or by vocal pedagogues. My 
research hopes to demonstrate that vocal variance by audiotape recording, taken within the 
premenstrual / menstrual phase and during the remainder of the cycle, can be objectively 
assessed by the singers themselves or by vocal pedagogues. 
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Three studies have used self-evaluating questionnaires, which I will also use, but not self-
evaluating audio testing. This aspect is critical because of the perception that professional 
singers are more sensitive to minor changes in vocalization that may not be discernible to a 
listener, even a pedagogue. The study that I will undertake extends current research in that 
it may reveal the audience cannot hear a difference whilst the singer is convinced there is a 
difference. The increased effort to produce, support and project the expected quality and 
quantity of sound may be an awareness of the singer but not aurally perceived. 
 
This research could result in a significant reduction in a singer’s anxiety if their sound 
remains professionally acceptable and perceptually unaffected during the critical few days 
every month. Information such as this would be a major contribution to the literature. 
However, if perceptual changes do occur, the singer could manage the problem with 
certain recommendations from voice and/or medical professionals. 
 
Further information needs to available for professional singers. Studies using only semi-
professional or professional singers and protocols that are more challenging would then be 
able to evaluate any results more effectively and accurately.  
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CHAPTER 2 
 
The University of Sydney Human Ethics Committee approved this study.  All 
documentation pertaining to the study is reprinted in Appendix 1. 
 
2.1 METHOD 
 
U2.1.1 Participants 
 
All participants in this study were students of western classical voice enrolled at the 
Sydney Conservatorium of Music, The University of Sydney, from the degree courses of 
Diploma of Opera, Bachelor of Music (Performance) and Bachelor of Music (Education). 
The pedagogue listeners were all members of the Vocal Unit Staff at the Conservatorium. 
Students and pedagogues were invited to participate by letter. All were given participant 
information sheets and consent forms were signed prior to enrolment in the study.  
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Table 1:  Participant characteristics. Allocated number in study, gender, age in 
years, years of singing experience, voice type, and for females only, cycle length 
(days), cycle regularity, use of contraception.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Male subject details were not completed in the diary by participants.  
Incomplete participants (3) dropped out of the study. 
Distribution:  22 females – 20 sopranos – 2 mezzo-sopranos 
  6 males – 1 tenor – 1 counter-tenor – 4 baritones  
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1 F 19 3 soprano 28 Y N N 
2 M        
3 F 26 9 soprano 32 Y N N 
4 F 27 16 soprano 24-30 N N N 
5         
6 M        
7 F 25 12 soprano 28 Y Y N 
8 F 22 8 soprano 29 Y Y N 
9         
10 F 18 2 soprano 21 Y N N 
11 F 24 7 soprano 30 Y N N 
12 F 22 5 soprano 27 Y Y N 
13 F 18 6 soprano 29 Y N N 
14 M        
15 M        
16 F 23 5 soprano 30 Y Y N 
17 F 21 8 soprano 28 Y Y N 
18 F 21 5 mezzo soprano 35-40 N N N 
19 F 25 10 soprano 28 N N N 
20 F 22 16 soprano 30 Y N N 
21 F 21 6 mezzo soprano 27 Y N N 
22 F 19 2 soprano 26 N N N 
23         
24 F 20 8 soprano 28 Y Y N 
25 F 23 7 soprano 29 Y Y N 
26 F 21 6 soprano 28 Y Y N 
27 F 18 9 soprano 25 Y Y N 
28 F 25 5 soprano 29 Y N N 
29 F 25 10 soprano 30 Y Y N 
30 M        
31 M        
 55 
U2.1.2 Instruments 
 
The diary was custom designed for this study and covered questions on physical 
symptoms, voice and mood states. The female participants were asked to record their daily 
temperature and their menstrual cycles.  Diaries were bound in thirty-six-page booklets. 
Participants were asked to complete one page per day for each day of the observation 
period. 
 
2.1.2.1 Physical symptoms questions 
 
Physical symptoms recorded were those described most commonly in the literature 
(Wicklund, 1996) as occurring in the pre-menstrual part of the cycle, with additional space 
for comments regarding the severity of the symptoms. The female subjects were asked 
whether they were using hormonal contraception.  
 
 
UTODAYU, did you:         
                not at all severe                        very severe 
experience cramps?      NO___YES______________________________________ 
feel fatigued?        NO___YES______________________________________ 
feel nauseous?        NO___YES______________________________________ 
feel bloated? (eg breasts?)     NO___YES______________________________________ 
experience food cravings?      NO___YES______________________________________ 
have headaches?       NO___YES______________________________________ 
change in appetite?       NO___YES______________________________________ 
feel dizzy?        NO___YES______________________________________ 
have difficulty sleeping last night? NO___YES______________________________________ 
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Data regarding state of “well being”, symptoms of inter-current illness (unwell), unrelated 
physical symptoms (body pain) and alcohol consumption (alcohol intake) were collected 
as these factors are also known to affect voice production and quality. 
 
2.1.2.2 Voice questions 
 
Items included in the questionnaire used to rate voice quality were selected on the basis 
that they are commonly used by vocal pedagogues and students to describe the voice and 
which occurred in the literature as descriptors of vocal health and quality (Abitbol et al, 
1999; Rubin, 2001; Sataloff, 2000). 
 
Thinking about your singing UtodayU, to what extent do you agree or disagree with the following: 
Strongly agree           Strongly disagree 
My voice felt in peak form   ___________________________________ 
My voice felt fatigued    ___________________________________ 
It took a lot of effort to sing   ___________________________________ 
My ability to support my sound was affected ___________________________________ 
My voice seemed hoarse or husky  ___________________________________ 
My voice felt muffled, weak or breathy  ___________________________________ 
I could not extend to the top of my range ___________________________________ 
I was not able to control my voice as easily ___________________________________ 
My voice felt “sluggish”   ___________________________________ 
My voice sounded flat in pitch   ___________________________________ 
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2.1.2.3 Mood state questions 
 
Words used to describe mood states were selected from each of the subscales of the Profile 
of Mood States (POMS) (McNair & Droppleman, 1981). Other vocal researchers 
(Abplanalp et al, 1979; Wicklund, 1996) have taken a similar approach to mood 
description in vocal research. 
 
Below is a list of feelings that people have. For each feeling, cross UONE U number for the answer 
that best describes HOW YOU ARE FEELING URIGHT NOW U. The numbers refer to these 
phrases   
0 = Not at all, 1 = A little, 2 = Moderately, 3 = Quite a lot, 4 = Very 
 
Relaxed   (0) (1) (2) (3) (4) 
Discouraged   (0) (1) (2) (3) (4) 
Annoyed / Irritable  (0) (1) (2) (3) (4) 
Sad / depressed   (0) (1) (2) (3) (4) 
Unable to Concentrate  (0) (1) (2) (3) (4) 
Energetic   (0) (1) (2) (3) (4) 
Forgetful / confused   (0) (1) (2) (3) (4) 
Tense / anxious   (0) (1) (2) (3) (4) 
Exhausted   (0) (1) (2) (3) (4) 
Cheerful   (0) (1) (2) (3) (4)  
Angry    (0) (1) (2) (3) (4) 
Fatigued   (0) (1) (2) (3) (4) 
Happy    (0) (1) (2) (3) (4) 
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2.1.2.4 Temperature chart 
 
The temperature chart was based on the chart used by the Family Planning Association of 
Australia and modified to suit the current study. Recording of basal temperature and 
change, “ovulation shift”, during the female menstrual cycle followed protocols based on 
physiology references and previous studies (Nix, 1998; Rhoades & Pflanzer, 1992; 
Williams & Wendell-Smith, 1966). 
 
U2.1.3 Procedure 
 
2.1.3.1 Stage 1 
 
The twenty-one (21) female singing students were asked to commence recording their 
temperature, day of cycle, mood and vocal states, physical symptoms and intercurrent 
illnesses in their daily diaries on day 1 of their menstrual cycle. Six (6) control males also 
recorded data, taking day 1 as the day on which they were given their diaries.  
 
2.1.3.2 Stage 2 
 
The six (6) female singers who indicated in their diaries that their menstrual cycle most 
affected their singing voices were audio-taped on two occasions, firstly on day 1 of their 
menstruation and again at mid-cycle. The students involved and the voice teachers at the 
Conservatorium assessed these samples to determine whether voices affected by hormonal 
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fluctuations could be reliably identified perceptually, when assessors were blind to the 
conditions under which the samples were produced.  
 
U2.1.4 Recording 
 
2.1.4.1 Musical tasks recorded 
 
The musical task recorded was twenty (20) seconds of a Puccini aria, O Mio Babbino Caro 
from the opera, Gianna Schicchi. This extract challenged each singer in range extension, 
sustained support of the voice, accuracy of intonation (pitch), flexibility of phrasing and 
movement through the registers, as well as language facility. 
 
We recorded arpeggios and other scale patterns and messa di voce at each session, but final 
analysis was confined to the aria extract as it revealed all the information appropriate to 
this study. Both musical tasks were chosen as very specific to the singing voice, in contrast 
to the many other studies conducted on the speaking and singing voices. This was a 
significant methodological advance in that vocal effects of the menstrual cycle might only 
be observed at the extreme range or technical challenge of the vocal stimulus. The nearest 
tests to western classical singing in previous studies have been chromatic scales and 
phrases (Brown et al, 1985), or a rendition of “Frère Jacques”, a French folk song (Abitbol 
et al, 1999). Both these tasks are still far removed in difficulty from the daily expectations 
of a professional singer who requires wider range and greater volume in pieces of music of 
much greater technical challenge. 
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2.1.4.2 Recording Method 
 
The recordings of the female singers who reported being most affected by the hormonal 
fluctuations were made at various times of the monthly cycle (day 1 and mid-cycle) when 
hormonal changes were noted from the information acquired by the self-evaluating 
questionnaire. 
 
The acoustic signals were recorded digitally (Behringer Ultragain preamplifier/Marantz 
CDR 630) via a high-quality microphone (AKG C-477) positioned on a head boom a 
constant 7 cm distance from the subject’s lips. That was so that direct energy of the 
performers’ voice was recorded rather than room reflections, enabling us to use a studio 
environment with low ambient noise. For calibration of absolute sound pressure levels 
(SPL), this was coupled to the microphone, at a distance of 7cm and played immediately 
following each recording session at the same recording gain.  A sound level meter (Rion 
NL-06 SPL) was used to measure the SPL, which was noted for the two tones. 
 
The taped samples were randomly aggregated onto a CD and both the pedagogues and the 
singers rated the vocal quality of the samples on a simple vocal quality rating scale. The 
singers also indicated whether the sample was taken during menses or at another time in 
the cycle.  
 
2.2 Study Design 
 
Participants recruited into the study were given a package, which included the self-
evaluating questionnaire, a temperature chart and a student information form. All 
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participants had a half-hour briefing prior to study commencement so that they understood 
how to complete the temperature chart and daily diary. Males completed only the vocal 
and general health sections of the daily diary and did not complete the temperature chart. 
 
Descriptive statistics were performed on demographic characteristics. Parametric and time 
series analyses were examined with regard to perceived hormonal effects on the voice. 
Acoustic analysis assessed the actual changes in voice quality over the menstrual cycle.  
 
2.3 Hypothesis 
 
The study was undertaken because, as a vocal pedagogue of 26 years experience, anecdotal 
evidence suggested that young western female classical singers affected by the 
premenstrual syndrome manifest significant vocal impairment. The multiplicity of the 
symptoms has a variable negative effect on the voice of young singers to the extent that 
they feel insecure in their performance. This suggested that further research was necessary 
in a clearly defined group with appropriately set tasks.  
 
The hypothesis was that young female singers would manifest changes in their singing 
voice, which could be self-detected, but also manifest changes in such a way as to be 
detectable by vocal pedagogues or an audience. The young male singers would act as 
controls with no apparent symptomatology. Failure of consistency and reliability of the 
voice could then be predicted by the fluctuations of the menstrual cycle, the mood states of 
the performer and their physical symptomatology. 
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CHAPTER 3 
 
RESULTS 
 
3.1 Description of sample 
 
One female singer with 17 days of missing data was omitted from analyses (ID #12) 
leaving 27 singers.  Where there were some missing diary days, these appeared to occur 
randomly.  One female singer (ID #17) had 8 days missing and one male singer (ID #6) 
had 6 days missing.  Of the remaining 25 singers, 11 had complete data and the remainder 
had between 1-4 days missing.  Thus, there were a total of 32 missing days for the voice 
quality variables out of 696 days recorded (4.6%). 
 
Of the 27 singers with sufficient Phase I data to be included in longitudinal analyses, 6 
were male and 21 were female.  Of the 6 males, 5 completed the diaries for 28 days and 
one completed the diaries for 26 days.  Of the 21 females, 14 completed the diaries for 28 
days, three for 27 days, three for 25 days and one for 18 days. 
 
3.2 Analysis 
 
Five types of analyses were conducted:  
 
i. Udescriptive analysesU using the entire data file of 28 singers; frequencies, box plots 
and t-tests were used to explore characteristics of the singers and associations 
between voice quality parameters and personal characteristics. 
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ii. Ucross-sectional analysesU in which the data for the 27 singers with adequate diary 
recording were used;  mean voice quality parameters were used to explore 
differences by day and gender, non parametric and parametric correlations were 
used to explore relationships between mood, feelings and voice quality, regression 
was used to describe relationships between mood and voice quality and one-way 
analysis of variance was used to examine linear trends in mood and voice quality 
over the first 7 days of the cycle in females. 
 
iii. Ulongitudinal analysesU in which data for the 27 singers with adequate values were 
used and in which missing values for each singer were replaced by their mean 
value for their cycle up to day 25.  Missing data was not replaced past the last day 
of recording.  General linear modelling with repeated measures analysis was used 
to test for day and gender effects and to obtain means plots and effect sizes.  When 
sample models were repeated using Mixed Models with autoregressive covariance 
matrices (AR(1)), the P values for the effect of gender and day of cycle were very 
similar to the repeated measures ANOVA effects for gender effects and similar for 
day effects.  
 
iv. Uperceptual analysisU of six female singers was completed by recording specific 
musical tasks during various times of the monthly cycle (day 1 and mid-cycle) 
when hormonal changes were noted from the information acquired by the self-
evaluating questionnaire. The taped samples were randomly aggregated onto a CD 
and both the pedagogues and the singers rated the vocal quality of the samples on a 
simple vocal quality rating scale. The singers also indicated whether the sample 
was taken during menses or at another time in the cycle.  
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v. Umeasurement of agreement:U  mood and voice quality variables for the 19 singers 
who completed both phase I and phase II were compared.  The difference for each 
day in phase I and II and the mean of the phase I and phase II measurements for the 
same day were computed and then plotted to assess agreement. 
 
3.3 Statistical methods 
 
A total of 27 singers, of whom 6 were male and 21 were female, provided sufficient data to 
be included in longitudinal analyses.  Of the 6 males, 5 completed the daily diaries for 28 
days and one completed the diaries for 26 days.  Of the 21 females, 14 completed the 
diaries for 28 days, three for 27 days, three for 25 days and one for 18 days. In order to 
include singers in longitudinal analyses, missing values were replaced by the singer’s 
mean value for their cycle but missing data was not replaced past the last day of recording.   
 
Linear mixed models were used to measure the independent effects of cycle (days 24-4 
compared with days 5-23), gender and contraceptive pill use included in binary form on 
voice quality and mood. The effect of contraceptive pill use was tested in females only. An 
autoregressive covariance matrix was used to allow for values closer together to be more 
correlated than values further apart. This covariance structure provided a lower-2 restricted 
log likelihood than either an unstructured matrix or compound symmetry matrix and was 
therefore used in the mixed models. The residual values for the models were normally 
distributed with no major outliers and therefore assumptions for the models were met. 
Repeated measures general linear models were then used to examine trends using a linear 
polynomial contrast in mood and voice quality over the first 4 days of the cycle. In 
addition, deviation contrasts were used in females only, to identify days where values were 
 65 
significantly higher or lower than the mean value for all time points. There was insufficient 
data to undertake this analysis in males. Relationships between voice quality 
measurements and mood were examined using Pearson’s correlation coefficients. 
 
3.4 Results 
 
U3.4.1 Characteristics of Singers 
 
The characteristics of the 27 singers are shown in Table 2.  None of the female singers was 
pregnant and only four reported having an irregular menstrual cycle. 
 
Table 2: Characteristics of singers 
 
  Total sample 
 Males Females 
Total number 6 21 
   
Soprano - 19 (91%) 
Mezzo soprano - 2    (9%) 
Baritone 4 (67%) - 
Tenor 1 (17%) - 
Counter tenor 1 (17%) - 
   
Age range (years) 19-29 18-27 
Singing (years) 3-9 2-16 
   
Oral contraceptive pill - 9 (43%) 
Regular cycles - 17 (81%) 
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Although 17/21 (81%) of females singers reported regular menstrual cycles and 10/21 
(43%) reported using an oral contraceptive, neither of these factors were related to the 
voice quality variables as measured on the first day of the cycle with P>0.15 for all 
associations (Appendix 2). The box plots of temperature in females showed that there was 
no apparent relationship between temperature and day of cycle (Appendix 3). 
 
Perception of voice quality for female singers were summarised as median values and the 
range for each day are shown as box plots in Appendix 4.  For the females for most 
variables, median values tended to be slightly lower on days 1-3 than for the remainder of 
the cycle and for some variables there was a trend for values to rise through days 1-7 as 
shown, for example, for ‘fatigue in Figure 1. 
 
Figure 1:  Box plots of ‘fatigue’ by day in females 
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The voice parameters for male singers summarised as median values and the range for 
each day are shown as box plots in Appendix 5.  Although some males had lower values 
on days 1 and 2, the plots tended to be slightly flatter over the cycle days than for females 
or more random as shown for ‘fatigue’ in Figure 2. 
 
Figure 2:  Box plots of ‘fatigue’ by day in males  
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U3.4.2 Trend for voice quality to improve over first 1-7 days of cycle in females 
 
One-way ANOVA was used to generate a polynomial term to measure whether there was a 
linear trend for the voice quality parameters to improve over the first 7 days of the cycle 
for both males and females.  The plots for females only over these days are shown in 
Appendix 10. 
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In males, there was a significant trend for fatigued voice to improve (P=0.01).  In females, 
there was a significant trend for fatigued voice (P=0.004), effort (P=0.045), support 
(P=0.047), control (P=0.04) and sluggishness (P=0.02) to improve and a marginally 
significant trend for peak form (P=0.07) to improve.  The means plot for ‘fatigued voice’ 
is shown in Figure 3.  
 
Figure 3:  Mean fatigued voice score from day 1-7 in females 
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Although mood improved somewhat in both males and females over days 1-7 as shown by 
reduced mood scores in both genders, the trend was not statistically significant (P=0.57 in 
males and P=0.1 in females).  The plot for females is shown in Figure 4.  
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Figure 4:  Mean total mood score over days 1-7 in females 
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U3.4.3 Perceived voice quality by cycle 
 
The mean values for voice quality for the first phase of the cycle (days 24-4) and the 
remainder of the cycle (days 5-23) are shown in Figure 5 for females and in Figure 6 for 
males.  The figure for females indicates a tendency for all measurements to be 
approximately one point lower on average during days 24-4 of the cycle whereas for males 
mean values tend to be more alike during the two phases except for peak form. There were 
slightly larger differences between cycle phases for all voice parameters increasing during 
days 5-23 for females but not for males. Repeated measures analysis of variance showed a 
significant difference between voice scores (P<0.001) with a voice by gender interaction 
(P=0.007) but the differences between cycle phases was not significant (P=0.13). 
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Figure 5:  Mean unadjusted voice quality in females during days 24-4 and days 5-23 
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Figure 6:  Mean unadjusted voice quality in males during days 24-4 and days 5-23 
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Figure 7 shows the mean score for mood and indicates that females had slightly lower 
mood during days 24-4 than for days 5-23, while for males there was no differences 
between the two phases. 
 
Figure 7:  Mean mood score by day in males and females 
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Table 3 shows the mean values of the voice quality and mood for selected days over the 
cycle in males and females.  Females tended to score lower on all voice quality 
measurements, especially on days 1 and 4.  For mood, female scores were on average 5-6 
points higher than males on days 1 and 4 but similar on days 14 and 23. 
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Table 3:  Mean values with standard deviations shown in brackets for voice 
quality measurements and mood on day 1, day 4, days 12-15 and day 23 of the cycle. 
*In the column for days 12-15, the highest mean value over the four days is shown, 
usually day 14 as shown in Table 5. 
 
  Day 1 Day 4 Days 12-15* Day 23 
      
Peak form Females 4.1 (2.5) 5.2 (2.6) 6.1 (2.9) 5.7 (2.4) 
 Males 5.8 (1.8) 6.7 (1.7) 7.0 (1.4) 6.7 (1.0) 
      
Fatigued  Females 4.1 (2.6) 5.2 (3.2) 6.9 (2.8) 6.7 (3.0) 
 Males 4.4 (2.6) 6.1 (2.4) 7.3 (2.8) 6.8 (1.9) 
      
Effort Females 4.1 (2.8) 5.4 (3.0) 6.9 (2.6) 6.2 (2.8) 
 Males 4.9 (2.6) 6.7 (2.6) 6.7 (2.0) 4.9 (2.4) 
      
Support Females 3.9 (2.8) 5.7 (3.1) 6.8 (2.4) 6.4 (3.2) 
 Males 4.2 (3.4) 6.1 (2.5) 6.5 (3.4) 6.3 (2.1) 
      
Hoarse Females 5.3 (3.1) 5.8 (3.2) 7.5 (2.1) 7.3 (2.9) 
 Males 7.7 (1.3) 7.0 (2.9) 7.6 (2.9) 7.3 (2.0) 
      
Weak Females 5.2 (3.1) 5.9 (3.2) 7.0 (2.9) 6.2 (3.2) 
 Males 6.5 (2.5) 7.5 (1.5) 8.0 (1.4) 6.7 (2.1) 
      
Range Females 4.9 (3.5) 5.8 (3.8) 7.6 (2.1) 7.1 (3.1) 
 Males 6.3 (3.4) 5.4 (2.2) 6.1 (3.7) 6.3 (3.2) 
      
Control Females 4.5 (3.2) 5.8 (3.4) 7.2 (2.9) 5.6 (3.6) 
 Males 5.9 (2.5) 6.5 (2.8) 6.6 (3.2) 6.7 (2.8) 
      
Sluggish Females 4.6 (3.3) 6.2 (3.0) 7.1 (2.9) 5.7 (3.2) 
 Males 6.2 (3.0) 6.6 (3.0) 7.3 (2.8) 7.1 (2.3) 
      
Pitch Females 6.3 (3.2) 6.7 (2.9) 7.1 (2.9) 6.6 (3.5) 
 Males 7.2 (2.5) 7.7 (2.1) 7.6 (3.6) 8.3 (2.3) 
      
Mood Females 22.0 (12.7) 19.1 (9.7) 13.5 (7.2) 16.9 (8.9) 
 Males 14.2 (7.9) 12.7 (5.4) 12.3 (5.9) 16.3 (7.2) 
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U3.4.4 Gender and cycle effects on voice quality and mood 
 
Table 4 shows the effects of gender and cycle (days 24-4 compared to day 5-23) on voice 
quality and mood as estimated using mixed model analyses.  The mean scores for males 
tended to be higher than for females for all variables except range and mood, and the 
standard errors were also higher in males indicating a wider range used on each scale. 
There was a significant difference in peak form between males and females (P<0.0001) 
and a marginally significant difference in weak voice (P=0.07) and sluggish voice 
(P=0.07), with males scoring higher on all measurements. The difference in mood with 
males scoring lower than females did not reach statistical significance at P=0.09. 
 
The estimated marginal mean values for cycle after adjusting for a gender influence are 
also shown in Table 4. The mean scores for voice quality tended to be lower as indicated 
by the negative values for mean difference, and mood tended to be higher as indicated by a 
positive mean difference in cycle days 24-4, when compared with cycle days 5-23. There 
was a statistically significant difference for fatigued voice (P=0.004) and effort (P=0.03). 
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Table 4:  Marginal mean values for voice quality and mood in males and females and for days 24-4 and days 5-23 of cycle 
estimated from mixed linear models for voice quality and mood measurements.  
 
 
Voice UGender effectU UCycle effectU 
quality Males Females  Days 24-4 Days 5-23  
measure Mean (SE) Mean (SE) Difference 
(95% CI) 
P value Mean (SE) Mean(SE) Difference  
(95% CI) 
P value 
Peak form 6.8 (0.3) 5.4 (0.2) 1.4 (0.7,2.1) <0.0001 5.9 (0.2) 6.3 (0.2) -0.3 (-0.8,0.2) 0.20 
Fatigued 6.2 (0.4) 5.6 (0.2) 0.6 (-0.2,1.4) 0.15 5.5 (0.3) 6.4 (0.2) -0.9 (-1.4,-0.3) 0.004 
Effort 6.1 (0.4) 5.7 (0.2) 0.4 (-0.4,1.2) 0.34 5.6 (0.3) 6.2 (0.2) -0.6 (-1.2,-0.1) 0.03 
Support 6.3 (0.4) 6.1 (0.2) 0.2 (-0.7,1.2) 0.62 6.2 (0.3) 6.2 (0.2) -0.1 (-0.7,0.5) 0.83 
Hoarse 7.1 (0.4) 6.5 (0.2) 0.6 (-0.3,1.5) 0.21 6.6 (0.3) 7.0 (0.3) -0.3 (-0.9,0.2) 0.26 
Weak 7.0 (0.4) 6.2 (0.2) 0.8 (-0.1,1.6) 0.07 6.6 (0.3) 6.7 (0.2) -0.1 (-0.7,0.5) 0.74 
Range 6.1 (0.4) 6.5 (0.2) -0.4 (-1.3,0.5) 0.34 6.2 (0.3) 6.4 (0.3) -0.3 (-0.9,0.3) 0.38 
Control 6.8 (0.4) 6.1 (0.2) 0.7 (-0.2,1.5) 0.13 6.3 (0.3) 6.6 (0.2) -0.3 (-0.9,0.3) 0.25 
Sluggish 7.0 (0.4) 6.2 (0.2) 0.8 (-0.1,1.6) 0.07 6.4 (0.3) 6.7 (0.2) -0.3 (-0.9,0.3) 0.34 
Flat 7.6 (0.4) 7.0 (0.2) 0.7 (-0.3,1.7) 0.17 7.3 (0.3) 7.3 (0.3) -0.1 (-0.7,0.5) 0.85 
Mood 14.9 (1.0) 16.9 (0.6) -2.0 (-4.3,0.3) 0.09 16.6 (0.8) 15.3 (0.7) 1.3 (-0.5,3.0) 0.16 
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Mean voice quality scores by day for effort and support are shown in Figure 8. For both 
measurements, the lowest point occurs at day 1, and there is a trend for voice quality to 
improve over the next few days followed by a peak at days 12-14. 
 
Figure 8: Relation between effort and support and day of cycle in females 
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The F values and P values for the repeated measures deviation contrasts are shown in 
Table 5. Mean values for voice quality measurements were lower on day 1 of the cycle for 
females with significant differences for all measurements except hoarse or weak voice, 
range and flat voice. In addition, the mean mood score was higher (i.e. worse) on day 1 
(P=0.05).  In addition, mean values for all voice quality measurements except support were 
significantly higher in the centre of the cycle, usually at day 14 but at day 12 for hoarse or 
flat voice and at day 15 for range. Mean mood score was significantly lower (i.e. better) at 
day 12 (P=0.001).  Day 1 was the lowest point in the cycle and therefore the trend from 
days 1 was tested.  Table 5 also shows the trend test over days 1-4 for both males and 
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females. There was a significant trend for voice quality measurements to improve over 
days 1-4 in females for peak form, effort, support and sluggish but there were no trends for 
voice quality to improve over these days in males. 
 
Table 5:  F and P value statistics from general linear repeated measures models 
to identify lowest and highest days of cycle in females only and for trends over days 1-
4 of cycle in both males and females 
 
Voice 
quality 
Day 1* 
Females 
Days 12-15* 
Females 
Days 1-4 
trend** 
Females 
Days 1-4 
trend** 
Males 
 F 
value 
P 
value 
Day F 
value 
P 
value 
F 
value 
P 
value 
F 
value 
P 
value 
Peak form 4.7 0.06 14 6.8 0.03 5.2 0.03 3.9 0.11 
Fatigued 7.5 0.02 14 25.5 0.001 2.0 0.17 3.9 0.11 
Effort 9.7 0.01 14 12.7 0.01 4.4 0.05 0.3 0.64 
Support 19.7 0.001 14 2.5 0.15 4.5 0.05 2.2 0.20 
Hoarse 2.5 0.15 12 11.7 0.01 1.2 0.29 0.1 0.75 
Weak 1.7 0.23 14 8.3 0.02 1.6 0.22 1.6 0.30 
Range 2.4 0.15 15 6.1 0.03 1.1 0.30 0.7 0.43 
Control 4.2 0.07 14 6.0 0.04 1.7 0.21 0.1 0.83 
Sluggish 8.0 0.02 14 6.7 0.03 5.1 0.04 0.1 0.88 
Flat 1.6 0.23 12 9.4 0.01 0.1 0.72 0.4 0.56 
Mood 4.9 0.05 12 16.7 0.001 1.9 0.18 0.3 0.64 
 
 
*   Deviation contrast with remainder of cycle                    
** Polynomial linear contrast 
 77 
U3.4.5 Effect of contraceptive pill 
 
Table 6 shows the effects of taking a contraceptive pill and cycle in females.  The negative 
mean differences for all voice quality measurements except peak form indicate that singers 
who were not taking a contraceptive pill tended to rate lower on the voice quality scores. 
They also rated almost two points higher on mood. The difference in mean values was 
significant for hoarse voice (P=0.003) and marginally significant for fatigued (P=0.07). 
The table also shows the estimated mean values for cycle in females only after adjusting 
for the influence of contraceptive pill use. After adjusting for the effect of taking a 
contraceptive pill, the mean values for all voice measurements again tended to be lower 
and mood tended to be worse in cycle days 24-4 than in days 5-23 with significant 
differences for fatigued voice (P=0.02) and a marginally significant difference for effort 
(P=0.06) and mood (P=0.07). 
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Table 6:  Marginal mean values for voice quality measurements and mood by contraceptive pill use and days 24-4 or days 5-23 of 
cycle estimated from mixed linear models for each measurement in females only.  
 
Voice UContraceptive pill effectU UCycle effectU 
Quality No Yes  Days 24-4 Days 5-23  
Measure Mean (SE) Mean (SE) Difference 
(95% CI) 
P value Mean (SE) Mean(SE) Difference  
(95% CI) 
P value 
Peak form 5.5 (0.3) 5.2 (0.3) 0.3 (-0.4,1.1) 0.37 5.1 (0.3) 5.6 (0.2) -0.4 (-1.0,0.1) 0.14 
Fatigued 5.3 (0.3) 6.1 (0.3) -0.8 (-1.6,0.1) 0.07 5.3 (0.3) 6.1 (0.2) -0.8 (-1.5,-0.1) 0.02 
Effort 5.5 (0.3) 6.0 (0.3) -0.5 (-1.3,0.3) 0.20 5.4 (0.3) 6.0 (0.2) -0.6 (-1.3,0.1) 0.06 
Support 5.9 (0.3) 6.3 (0.3) -0.5 (-1.3,0.7) 0.49 6.1 (0.3) 6.1 (0.3) 0.1 (-0.7,0.7) 0.98 
Hoarse 5.9 (0.3) 7.3 (0.3) -1.3 (-2.2,-0.5) 0.003 6.4 (0.3) 6.8 (0.2) -0.4 (-1.0,0.3) 0.24 
Weak 6.1 (0.3) 6.5 (0.3) -0.4 (-1.2,0.4) 0.31 6.2 (0.3) 6.4 (0.2) -0.2 (-0.9,0.5) 0.57 
Range 6.2 (0.3) 6.9 (0.3) -0.8 (-1.6,0.1) 0.10 6.4 (0.3) 6.7 (0.2) -0.4 (-1.1,0.3) 0.28 
Control 5.8 (0.3) 6.4 (0.3) -0.6 (-1.5,0.2) 0.15 5.9 (0.3) 6.3 (0.2) -0.4 (-1.1,0.3) 0.24 
Sluggish 6.1 (0.3) 6.2 (0.3) -0.1 (-0.9,0.7) 0.85 6.0 (0.3) 6.4 (0.2) -0.4 (-1.0,0.3) 0.30 
Flat 6.8 (0.3) 7.1 (0.3) -0.3 (-1.2,0.6) 0.49 7.0 (0.3) 7.0 (0.3) -0.1 (-0.7,0.7) 0.87 
Mood 17.8 (0.7) 16.0 (0.8) 1.8 (-0.4,4.0) 0.10 17.8 (0.9) 15.9 (0.6) 1.9 (-0.1,3.9) 0.07 
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U3.4.6 Relation between voice quality and mood 
 
All significant correlations are negative indicating reduced voice quality with more 
negative mood experiences.  The correlations with total mood score are more 
consistent with most voice quality measurements related or marginally related to mood 
on days 1, 3 and 18 with some correlations remaining over the other days.   
 
Total mood score is more normally distributed than the individual scores and therefore 
parametric correlation coefficients and regression are appropriate.  The plots of each 
sing variable for day 1 against the total mood score for females are shown in Appendix 
9.  Each figure in the appendix shows the scatter plot, the regression equation and the 
R square value.  The plot for ‘Voice feeling sluggish’ is shown in Figure 9 below – the 
R square value of 0.45 indicates that 45% of the variation in voice feeling sluggish is 
explained by mood.  The amount of variation explained by mood in the other voice 
quality parameters was as follows: peak 20%, fatigue 17%, effort 7%, support 25%, 
hoarse 20%, weak 22%, range 22%, control 24% and pitch 34%. 
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Figure 9: Relation between feeling the voice is sluggish and total mood score 
 
 
 
 
 
 
 
 
 
 
 
Table 7 shows that there was a negative correlation between voice quality and mood for all 
measurements on days 1, 4, 14 and 23 indicating poor mood with reduced voice quality. 
Correlations greater than 0.43, which indicate that approximately 40% of the variation in 
mood was explained by voice quality, were statistically significant. Most of the significant 
associations occurred on days 1 and 14. 
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Table 7:  Correlation between voice quality measurements and mood on days 1, 
4, 14 and 23 in female singers. The table shows Pearson’s r-value with the P value in 
brackets 
 
 Day 1 Day 4 Day 14 Day 23 
Peak form -0.45 (0.04) -0.28 (0.22) -0.43 (0.05) -0.20 (0.41) 
Fatigued voice -0.41 (0.07) -0.28 (0.21) -0.53 (0.01) -0.47 (0.04) 
Effort -0.27 (0.24) -0.51 (0.02) -0.42 (0.06) -0.29 (0.22) 
Support -0.50 (0.02) -0.24 (0.29 -0.37 (0.10) -0.14 (0.55) 
Hoarse -0.45 (0.04) -0.39 (0.08) -0.49 (0.02) -0.37 (0.11) 
Weak -0.47 (0.03) -0.29 (0.21) -0.51 (0.02) -0.32 (0.16) 
Range -0.33 (0.14) -0.34 (0.14) -0.33 (0.15) -0.24 (0.31) 
Control -0.49 (0.03) -0.48 (0.03) -0.50 (0.02) -0.33 (0.16) 
Sluggish -0.67 (0.001) -0.40 (0.07) -0.49 (0.03) -0.23 (0.33) 
Pitch -0.58 (0.01) -0.20 (0.38) -0.66 (0.001) -0.19 (0.41) 
 
The negative association between fatigue and mood at day 14 in females is shown in 
Figure 10 with voice quality decreasing as mood score increases, i.e. mood deteriorates. 
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Figure 10:  Association between fatigue and total mood score in females at day 14 
 
 
U3.4.7  Relation between voice quality and feelings 
 
Non-parametric Kendall correlations were used to measure the relation between daily 
feelings (VAS scores) and voice quality in females on Days, 1, 3, 7, 14 and 18 of the cycle 
as shown in Appendix 6.  In each table, only the singers with complete data for the day are 
included.  To increase the validity of comparing correlations over the cycle, the analyses 
were undertaken up to day 18 to include the one singer who only completed 18 cycle days. 
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In general, there were some correlations between voice quality parameters and VAS scores 
each day. For some correlations, there are marginal P values of 0.05-0.1 when the 
correlation (r-value) is moderate at above 0.30.  However, some associations, for example 
with cravings and headaches, were in the direction opposite to expected, that is voice 
quality improved as daily feelings decreased.  This occurred when most singers recorded 
zero for the VAS scores and the correlation was therefore significantly influenced by the 
few singers with a non-zero rating. 
 
U3.4.8  Perceptual analysis of six female singers 
 
Figure 11 shows the pedagogue scores for each student during normal or menstruating 
phases.  Variations in pedagogue scores were wide with the smallest range of 4.7-7.1 for 
singer ID 21 and the largest range of 1.7-5.9 for singer ID 22. There was no consistent 
change in direction of scores during menstruating and non-menstruating phases with scores 
tending to decrease for four singers and increase for one singer. For the singer who 
provided data only during the non-menstruating phase, the scores were equally variable. 
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Figure 11:  Pedagogue scores for each student 
 
 
 
Five of the six singers who were selected on the basis of the worst self-reported vocal 
symptoms during menstruation correctly identified their performance during menstruation 
when presented blind with both their recordings (one during menstruation and one not). 
Figure 12, below, shows the self-rated scores for each singer. Two singers (ID 21 and 27) 
rated themselves consistently and highly but for the other four singers the ratings across 
voice quality were inconsistent and variable. 
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Figure 12: Self-rated scores for each singer 
 
 
Perceptual analysis of six female singers demonstrated a wide variation in pedagogue 
scoring during both normal and menstruating phases, with no consistent change. However, 
the students, who were selected based on the worst self-reported vocal symptoms during 
menstruation, correctly identified their performance during menstruation when presented 
blind with both their recordings. 
 
U3.4.9  Measurement of agreement 
 
Mood and voice quality variables for the 19 singers who completed both phase I and phase 
II were compared.  The difference for each day in phase I and II and the mean of the phase 
I and phase II measurements for the same day were computed and then plotted to assess 
agreement. 
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The mean-vs-differences plots for total mood score and the voice quality parameters to 
measure agreement between two cycles are shown in Appendix 12.  
 
For all variables, the R square value and the mean and the intercept of the regression 
through the plot is close to zero indicating no systematic bias for the same days during two 
consecutive cycles.  However, the scatter is not clustered around the zero line of no 
difference indicating wide variation in scores between the same day over two cycles. For 
mood, the plot widens as mood scores increase indicating less agreement at higher mood 
scores than at lower mood scores. 
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CHAPTER 4 
 
DISCUSSION 
 
This study is of considerable importance to the singing community, representing a detailed 
longitudinal study of the effects of the fluctuations of hormones over the menstrual cycle 
on the female classical singing voice.  Singing is a demanding profession, requiring all 
body systems to function optimally. Singers are generally described as vocal athletes 
whose career and livelihood depends on the optimal functioning of their instrument (i.e. 
the whole body).  This study makes a unique contribution to the management and 
pedagogy of female singers in the western classical tradition.  Specifically designed for 
advanced singers, it represents one of only a very few studies that used technically 
challenging musical tasks and repeated measures longitudinal design to investigate the 
research questions of interest.. 
 
This study examined the effect of the menstrual cycle on the western female classical 
singing voice. Participants were singing students studying at the Sydney Conservatorium 
of Music, The University of Sydney. Twenty-one young western female students and six 
young male singing students kept diaries of their perceived vocal quality and mood state 
every day for one month (male) or two months (female). Results indicated that some 
singers were not affected during their cycle, while others reported a range of problems 
from mild to severe symptoms and perceived reductions in their vocal quality particularly 
during the first seven days of the cycle. The six females who reported being most severely 
affected by their hormone cycle were asked to record specific vocal tasks at specific times 
in the menstrual cycle, firstly during day 1 of the menstrual cycle  and again at mid-cycle, 
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between  days 10-14. Both expert vocal pedagogues and the six selected singers completed 
perceptual assessments. While five of the six singers correctly identified their song sample 
made during menstruation, expert listeners were unable to reliably identify the ‘menstrual’ 
sample. 
 
Although male singers were included in the study as a control group to ascertain to what 
extent mood and vocal quality fluctuated from day to day without the influence of the 
female hormones, we were surprised to observe the degree to which the male singers 
fluctuated over the 28 days of their diary recordings. These fluctuations were less 
pronounced than for the females and showed no recognisable points of reference to 
calendar days. Personal communications with Professor Alfred Steinbeck MD BS (Syd) 
PhD (Lond) FRCP (Lond) FRACP, Specialist Endocrinologist, University of New South 
Wales, Sydney, and Clinical Associate Professor Katharine Steinbeck MB BS PhD 
FRACP, Staff Specialist in Endocrinology and Adolescent Medicine, Royal Prince Alfred 
Hospital, Sydney, confirmed that cyclical changes in males are known to occur on a 
diurnal basis (24-hourly) with hormone levels highest in the morning and falling towards 
midnight. A study by Ankarberg and Norjavaara (1999) in healthy girls before and during 
puberty, up to two years post-menarche, demonstrated that the same diurnal variation of 
testosterone occurs in females. Apparently, studies attempting to show that males have 
cyclical changes in a broader sense (monthly) similar to the female cycle have been 
unsuccessful previously and neither professor knew of any current research that 
demonstrated such a cycle.  
 
Women are known to suffer from premenstrual symptomatology to varying degrees as 
ascertained from a large body of literature (Abitbol, de Brux, Millot, Masson, Mimoun, 
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Pau & Abitbol, 1989). A diagnosis of premenstrual syndrome is only established if 
symptoms resolve for at least those days between the end of the menstrual period and 
ovulation, i.e. approximately days seven to fourteen of the cycle. Nader (1991) separated 
significant individual cyclical variation of symptomatology surrounding the menstrual 
cycle, with premenstrual symptoms varying from mild to severe. About 30-40% women 
experience some form of pre-menstrual symptoms, and 10% of women experience severe 
symptoms. Nader (1991) classified the signs and symptoms of the syndrome into somatic 
(body states), affective (mood states), pain and behavioural states and other symptoms, 
such as food cravings, insomnia and fatigue. The participants recorded a daily diary related 
to the menstrual cycle, with physical symptoms based on those most commonly described 
in the literature (Nader, 1991; Wicklund, 1966).  
 
4.1 Body states 
 
The females were asked to record whether they were using hormonal contraception and 
other symptoms such as inter-current illness, unrelated physical symptoms, e.g. body pain, 
and alcohol intake were also recorded, as such factors could influence voice production 
and quality. 
 
The effects of the cycle were assessed in a number of ways. We were interested in the 
variations over the first seven days of the cycle, assessed from the first day of bleeding. A 
second set of analyses comparing two parts of the cycle were also undertaken. The cycle 
was divided into the premenstrual and menstrual phase (days 24–4) when symptoms tend 
to be at their maximum and these days were compared to the remainder of the cycle (days 
5–23).   
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In female participants, the degree of severity of symptoms varied widely, in agreement 
with Sommer (1978), and was not always consistent between the two cycles recorded by 
the same participant. After adjusting for the effect of taking a contraceptive pill, the mean 
values for all voice measurements again tended to be lower and mood tended to be worse 
(higher mood scores) in cycle days 24-4 than in days 5-23, with significant differences for 
fatigued voice and a marginally significant difference for effort and mood.  
 
The effect of the contraceptive pill on the female cycle showed that those taking the 
medication rated their voice quality higher than those without medication, but their mood 
was lower than those not on the pill. This supports the research by Ledger and Davidson 
(in Comins, 2002) that the contraceptive pill has a stabilising effect on the voice and 
benefits female singers. In contrast to the perceived improvement in voice quality through 
the stable supply of extrinsic hormones to the body, there also appears to be more 
depression of mood because of the pill. Female singers report reluctance to use the 
contraceptive pill because of perceived changes that medication may have on their 
instrument, although there has been no scientific evidence to support this (Comins, 2002).  
 
Despite the observation by Boulet and Oddens (1996) that combined oral contraception 
(oestrogen & progesterone) has a negative effect in only 5% of women, the use of various 
combinations of oral contraception in western classical female singers remains a large 
untapped source of further study. More recently, Amir et al (2003 & 2004) demonstrated 
that low-dose monophasic contraceptive pill does not show an adverse effect on the voice, 
while their 2003 study suggested that voice stability is associated with the smaller 
hormonal fluctuations induced by the contraceptive pill. However, singers who were not 
taking a contraceptive pill tended to rate lower on all voice quality scores, except peak 
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form, but they also rated almost two points higher on mood on cycle days 24-4. This result 
demonstrated that there is a negative association between vocal fatigue and mood, with 
voice quality (fatigue) decreasing as mood deteriorates.  
 
With regard to the effort required to produce the voice and physical support of the voice 
measured against vocal quality, data showed that after a distinct low at day 1, voice quality 
improved to a peak at days 12-14 and was maintained almost through to the next 
premenstrual phase. Data also supported the anecdotal evidence from singers that their 
support and effort reduces the mean voice quality through the cycle days, i.e. their voice is 
not functioning as well initially, but tends to improve through the remainder of the cycle. 
These observations substantiate female subjective reports that they feel at their worst on or 
around the first day of the menses. 
 
The variation in reaction to premenstrual symptoms is due in part to the fluctuations of 
oestrogen and progesterone concentrations during the menstrual cycle resulting in variable 
symptoms and, in part, by the way in which individuals cope psychologically with the 
physiological changes at that time of month. However, not all women experience the 
premenstrual syndrome, and when evident it is highly variable in symptomatology (Chae 
et al, 2001). Some singers are affected by the changes and some are not (Isenberger, 
Brown & Rothman, 1985). Some women manifest the effects more obviously in relation to 
the fine motor tasks that they require to maintain their reputation, notably singers in major 
opera houses and concert performers in recital and oratorio. These findings may also be 
applied to other fields of vocal endeavour, such as music theatre and contemporary 
vocalists. 
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4.2 Voice states 
 
Voice quality is integral to a successful career in the professional singer and Rubin (2001) 
stated that nothing is static about the larynx or the vocal tract. With respect to singers, 
“laryngopathia premenstrualis” is caused by physiological, anatomical and psychological 
alterations because of endocrine changes (Sataloff et al, 1993). Premenstrual symptoms 
have been described in the literature for over forty years (Smith-Frable, 1962) and studied 
in various ways with diverse groups of people (Amir & Biron-Shental, 2004). Scientific 
confirmation of the aetiology has been debated (Davis & Davis, 1993; Nader, 1991).  
Abitbol et al (in Emerich et al, 1996) state that menstruation affects voice through changes 
in oestrogen levels throughout the cycle, which cause laryngeal water retention, oedema of 
interstitial tissues and venous dilatation.  
 
Abramson et al (in Emerich et al, 1996) state that altered metabolic activity by oestrogen 
sensitive cells could have an effect on the quality of the voice, since vocal fold hormonal 
receptor sites are sensitive to oestrogen, progesterone and thyroid hormone. More recently 
these hormone receptors have been demonstrated in the human vocal folds (Altman et al, 
2003) (Newman et al, 2000) and should lead to more defined clinical reasons for the 
variations of the singing voice. Through the various physiological feed back pathways and 
the neuro-endocrine system, mood and body states of the singer will influence the level of 
hormone production, in turn triggering the receptor sites in the vocal folds. 
 
While some cyclical variation was observed in both sexes, the results for the male singers 
were more random than those observed in females. There was a trend for the voice quality 
parameters to improve over the first seven days of the cycle for both males and females, 
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showing a similar pattern of improvement; however, the male pattern commenced on a 
random day 1, as opposed to the physiological day 1 in the female cycle. While this may 
suggest that recording symptoms in a diary format arouses the awareness of the observer to 
their own symptomatology, another potential source of research, it also agrees with 
Bradley (1980) who observed that singers are very aware of their bodies throughout 
performances and that this enables them to control the unwanted effects of physiological 
changes. 
 
Women consistently rated their voice lower than the men, which was plotted as mean 
unadjusted voice quality. The males manifested virtually no difference between the two 
cycle phases except for peak form and fatigued voice, while the females showed some 
difference in the cycle phases for nearly all recorded symptoms.  
 
The different effects of gender and cycle on voice quality and mood showed that males 
scored higher than females for all qualities except range and mood, while also using a 
greater range of scores to record their symptoms. Male singers rated peak form 
significantly higher than female singers while there was only a marginal difference 
between men and women in rating of weak voice and sluggish voice. Over the cycle, 
fatigued voice improved significantly in both males and females but the women also 
improved in their effort, support, control and sluggishness, and to a lesser extent peak 
form. 
 
It was also demonstrated that there is a distinct relationship between perceived voice 
quality and mood. Perceived voice quality between the first phase of the cycle (days 24-4) 
and the remainder of the cycle (days 5-23) indicated a tendency in females for all 
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measurements to be lower, on average, during days 24-4 of the cycle, whereas for males 
mean values tend to be more alike during the two phases, except for peak form. In fact, 
mood had a stronger effect on the voice than the contraceptive pill, an interesting and 
somewhat unexpected finding.  
 
Results supported the hypothesis that the voice is perceived to be affected by the menstrual 
cycle and its inherent physiological changes. However, the effects were no uniform across 
all singers, a finding also observed by Brown et al (1985), who used trained singers, some 
of whom were taking the contraceptive pill. Their assessment included singing tasks such 
as chromatic scales and phrases where the voices revealed the most difficulty in phonation. 
 
4.3 Mood states 
 
This research demonstrated that there was wide variation in scores of mood and voice 
quality between the same days over two cycles. Mood varied more obviously than voice 
quality, with worse moods (higher scores) showing greater variation in vocal quality. 
Mood improved somewhat in both males and females over days 1-7 as shown by reduced 
mood scores in both genders, although the trend was not statistically significant. The 
overall mood score was not significantly different between males and females, although 
males consistently rated their mood as better than females. 
 
In females, most ratings tended to be slightly lower on days 1-3 than for the remainder of 
the cycle and for some ratings there was a trend for values to rise through days 1-7. Poor 
mood was directly associated with perceived reduced voice quality for all days throughout 
the cycle and was significantly greater on days 1 and 14. Similarly, there was a negative 
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association between fatigue and mood at day 14, the peak in hormone secretion around 
ovulation. The effect of the menses, withdrawal of hormones, is well documented; 
however, the mid-cycle peak of hormones also apparently affects the voice detrimentally 
in association with body and mood states; another potential source of further research. 
 
However, singers’ awareness of vocal distress and low mood is not necessarily transmitted 
to their audience. Consequently, singers’ education should include information that their 
perceptions regarding their vocal quality may not adversely affect perceptual quality.  
 
4.4 Temperature 
 
Temperature chart recordings throughout the two cycles showed that there was no apparent 
relationship between temperature and day of cycle in this study. There was a wide 
variation in temperature in the females involved in the study with some showing marked 
fluctuations, while others recorded virtually no change. Physiology texts such as Rhoades 
and Pflanzer (1992) state that after ovulation body temperature quickly rises approximately 
1P0 PC and remains at this normal level until the onset of the next cycle. However, the same 
text states that the magnitude of the oscillations in body temperature associated with the 
menstrual cycle varies with the individual and that ovulation can occur in the absence of a 
detectable change in body temperature.  
 
There is potential for measurement error in students unused to taking and recording their 
temperatures for experimental purposes.. However, each singer was provided with a high 
quality, digitally recording thermometer, so the more likely explanation for the lack of 
association between temperature and day of cycle is that the measures of central tendency 
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that were used to assess this association may have obscured particular associations within 
individuals between these two factors. 
 
These explanations notwithstanding, the findings are generally at odds with the use of 
temperature charting in clinical medicine (such as used by the Family Planning 
Association clinics in Australia), which is used to help ascertain the date of ovulation. This 
study demonstrated approximately equal numbers of participants who recorded a 
temperature rise and those that did not record any rise. Similarly, females taking oral 
contraception recorded temperature quite variably in this study, considering that the effect 
of a consistent dose of ingested oestrogen would tend to reduce the potential temperature 
rise that is associated with the oestrogen peak of the mid-cycle. Of those most affected by 
their cyclical symptoms, four were not taking the pill and two were using oral 
contraception, yet only one in each subgroup recorded an obvious temperature rise. Future 
research will document more precisely the hormone content of the pill taken and how the 
various groups of hormones may effect the menstrual cycle, including temperature 
changes. 
 
4.5 Singer analysis 
 
Five of the six singers who were selected on the basis of the worst self-reported vocal 
symptoms during menstruation correctly identified their performance during menstruation 
when presented blind with both their recordings (one on the first day of menstruation and 
one at approximately mid-cycle). Analysis of their diary data also showed that there was a 
wide variation during both normal and menstruating phases, but with no consistent 
changes observed.  
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Lacina (in Chae et al, 2001) reported that many female singers had difficulty with intricate 
phonation control before each menstruation. Lacina also reported (1968) that the changes 
to the voice appear proportional to the presenting severity of the premenstrual symptoms, 
with which this research is in agreement. Sataloff (2002) also stated that singers are trained 
to discern subtle differences in the supernormal to near-perfect range in which the 
professional performer’s body must operate.  
 
4.6 Pedagogue analysis 
 
Perceptual analysis of the six female singers demonstrated a wide variation in perceptual 
ratings and there was no consistent change in direction of those scores during menstruating 
and non-menstruating phases. Essentially, the pedagogues were unable to distinguish 
clearly between the two phases of the cycle.. No comparative data was noted in the 
literature reviewed, and the perceptual effect on independent, blinded listeners is a fruitful 
area of new research in singing. 
 
4.7 Future directions 
 
There were some limitations of the research, as multiple observations had to be made on 
many days, involving data collection over two non-contiguous months. Twice daily input 
of information (discipline) required dedication of all the participants, which can both 
contribute to observer error / bias and potential ‘fudging’ of results, i.e. using the same 
observations to fill in the second results for the day. . 
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Blood samples would no doubt give more accurate indications of actual hormonal 
fluctuations during the female cycle (maybe the male cycle also) and could be used in 
further research. However, this is an invasive and expensive procedure, especially with the 
periodicity required to ascertain hormone status at different times of cycle.  
 
Future studies could possibly include blood sampling of participants for female hormone 
levels (oestrogen & progesterone), as well as the potential effects of insulin or sugar levels 
(diabetes effect) and thyroid hormone on the voice. As far back as 1971, Brodnitz stated 
that 14.1% of voice disorders could be traced to some endocrine cause, whilst 15% of 
disorders are caused by hormone-related drugs. Currently, Lã and Davidson (2005) are 
undertaking a systematic investigation on the effects of a third generation oral 
contraceptive pill (OCP) on the female operatic singing voice at the Music Department of 
the University of the University of Sheffield in England.  
 
Deeper knowledge of hormonal effects would require greater willingness / commitment of 
the participants and more strictly controlled studies. This would certainly add to the 
specific body of knowledge of singers and potentially to those who may be compromised 
by a medically treatable illness. In the broader sphere, this may assist all categories of 
voice users who rely on phonation as the medium of their profession.  
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CONCLUSION 
 
This study indicated that the female hormonal cycle had a perceptual effect on the voice of 
the young female western classical singer for the singers who reported being affected by 
menstrual symptoms. Not everyone reported symptoms and there was wide variation in 
symptomatology. However, the results indicated that a percentage of singers were severely 
affected. These singers find the demands of co-ordinating their body more challenging, 
vocalization takes more effort and at these times singing was less aurally and artistically 
rewarding. However, well-recognised singing teachers generally could not identify loss of 
vocal quality during menses in those singers.  
 
The study demonstrated that self-awareness by the artist is much more sensitive and 
critical than any perception of a highly trained observer, implying that audience 
satisfaction is not necessarily as difficult to achieve as self-satisfaction.  
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The University of Sydney 
 
SYDNEY CONSERVATORIUM  
OF MUSIC  
 
 
 
A/Professor Dianna Kenny 
Australian Centre for Applied Research in Music Performance 
 
 
ATTENTION:  SINGING STUDENTS 
 
 
Singing students of the Conservatorium are invited to 
participate in a research study on the effects of the hormonal 
cycle on the voice. Male students are also required to act as 
control subjects (for comparative purposes). Students who 
agree to participate will be briefed at a convenient time & venue 
at the Conservatorium.  
 
Maree Ryan 
A/Prof Dianna Kenny 
 
 
Please contact Maree Ryan 
at the Sydney Conservatorium of Music by telephone 9351 1259 or by email 
mryan@greenway.usyd.edu.au 
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The University of Sydney 
 
SYDNEY CONSERVATORIUM  
OF MUSIC  
 
CONSENT FORM 
 
 
I, ............................................................... , (please print) 
 
give consent to my participation in the research project 
 
RESEARCH STUDY INTO THE EFFECTS OF THE HORMONAL CYCLE ON THE 
HUMAN VOICE 
 
In giving my consent I acknowledge that: 
 
1. The procedures required for the project have been explained to me, and any 
questions I have about the project have been answered to my satisfaction; 
2. I have read the Subject Information Statement and have been given the 
opportunity to discuss the information and my involvement in the project with 
family and /or friends. 
3. I am aware of any risks or inconveniences associated with the project; 
4. I understand that I can withdraw from the study at any time, without affecting my 
relationships with the researcher(s) now or in the future. 
5. I understand that my involvement is strictly confidential and no information 
about me will be used in any way, which reveals my identity. 
 
 
Signed: ....................................................  Date: .................................... 
 
Name: .................................................... (please print) 
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The University of Sydney 
 
SYDNEY CONSERVATORIUM  
OF MUSIC  
 
 
A/Professor Dianna Kenny 
Australian Centre for Applied Research in Music Performances 
 
SUBJECT INFORMATION SHEET (Female) 
 
RESEARCH STUDY INTO EFFECTS OF THE HORMONAL CYCLE ON THE HUMAN VOICE 
 
You are invited to take part in a research project into the effects of hormonal fluctuation on the singing voice. 
UThis research study is to be known as the “Effect of Premenstrual Symptoms on Singers”.U 
 
The aim is to investigate the variability of the singing voice due to the effect of certain conditions relevant to 
professional singers. Any adverse effect on the voice that changes quality, ease of production and range can 
cause anxiety in a singer and have an adverse effect on confidence and ultimately career. 
 
The study is being conducted by Ms Maree Ryan, full time lecturer in voice at the Sydney Conservatorium of 
Music, under the supervision of Associate Professor Dianna Kenny from the Australian Centre for Applied 
Research in Music Performance. It forms the basis of a Masters Degree by Research and meets the ethics 
requirements of The University of Sydney into research with human subjects. 
 
If you agree to participate in this study, you will be asked to fill in a daily diary as part of a self-evaluating 
questionnaire, Ufor the time span of two (2) separate months. U You will also need to take your temperature 
Usublingually (under the tongue) by digital thermometer U every morning Uin those same monthsU and fill in a 
daily temperature chart Uto show that there are definitive changes in the basal body temperature of female 
subjects. U These procedures should not take longer than a few minutes each day. At a later date, a smaller 
number of volunteers will be required for audiotape recording, Uof no longer than 30 minutes on two (2) 
separate occasions, U to ascertain the levels of perceived changes when hormone levels in the body change. 
UThese perceived changes will be assessed by independent experts/pedagogues.U There are no risks involved in 
this research which will be carried out at the Sydney Conservatorium of Music in a staff singing studio. 
 
All collected data from the study will be strictly confidential and only Maree Ryan and Associate Professor 
Dianna Kenny will have direct access to information about the participants. A report of the study may be 
submitted for publication but individual participants will not be able to be identified from such a report. Only 
an allocated number will identify each subject and information will be stored in a locked area within the 
University premises until it is destroyed at the completion of the mandatory storage period of seven (7) years. 
 
Participation in this study is entirely voluntary and withdrawal will not jeopardize your future academic 
progress in any way. 
 
When you have read this information Maree Ryan will be happy to discuss it with you further and answer any 
questions that you may have about the study. If you would like to know more at any stage, please feel free to 
contact Maree Ryan, Lecturer in Voice, Sydney Conservatorium of Music, by telephone on (02) 9351 1259 
or by email at TUmryan@greenway.usyd.edu.au UT or Associate Professor Dianna Kenny by telephone on (02) 
9351 1386 or by email at TUd.kenny@fhs.usyd.edu.auUT  
 
This information sheet is for you to keep. 
 
Any person with concerns or complaints about the conduct of this research can contact the 
Manager for Ethics Administration at The University of Sydney on (02) 9351 4811. 
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The University of Sydney 
 
SYDNEY CONSERVATORIUM  
OF MUSIC  
A/Professor Dianna Kenny 
Australian Centre for Applied Research in Music Performance 
 
SUBJECT INFORMATION SHEET (Male) 
 
RESEARCH STUDY INTO EFFECTS OF THE HORMONAL CYCLE ON THE HUMAN VOICE 
 
You are invited to take part in a research project into the effects of hormonal fluctuation on the singing voice. 
UAs a male subject you will be used in the control group.U UThis research study is to be known as the “Effect of 
Premenstrual Symptoms on Singers”.U 
 
The aim is to investigate the variability of the singing voice due to the effect of certain conditions relevant to 
professional singers. Any adverse effect on the voice that changes quality, ease of production and range can 
cause anxiety in a singer and have an adverse effect on confidence and ultimately career. 
 
The study is being conducted by Ms Maree Ryan, full time lecturer in voice at the Sydney Conservatorium of 
Music, under the supervision of Associate Professor Dianna Kenny from the Australian Centre for Applied 
Research in Music Performance. It forms the basis of a Masters Degree by Research and meets the ethics 
requirements of The University of Sydney into research with human subjects. 
 
If you agree to participate in this study, you will be asked to fill in a daily diary as part of a self-evaluating 
questionnaire, Ufor the time span of two (2) separate months. U You will also need to take your temperature 
Usublingually (under the tongue) by digital thermometer U every morning Uin those same monthsU and fill in a 
daily temperature chart Uto show that there are no significant changes in the basal body temperature of male 
subjects. U These procedures should not take longer than a few minutes each day. At a later date, a smaller 
number of UfemaleU volunteers will be required for audiotape recording, to ascertain the levels of perceived 
changes when hormone levels in the body change. UThese perceived changes will be assessed by independent 
experts/pedagogues. U There are no risks involved in this research which will be carried out at the Sydney 
Conservatorium of Music in a staff singing studio. 
 
All collected data from the study will be strictly confidential and only Maree Ryan and Associate Professor 
Dianna Kenny will have direct access to information about the participants. A report of the study may be 
submitted for publication but individual participants will not be able to be identified from such a report. Only 
an allocated number will identify each subject and information will be stored in a locked area within the 
University premises until it is destroyed at the completion of the mandatory storage period of seven (7) years. 
 
Participation in this study is entirely voluntary and withdrawal will not jeopardize your future academic 
progress in any way. 
 
When you have read this information Maree Ryan will be happy to discuss it with you further and answer any 
questions that you may have about the study. If you would like to know more at any stage, please feel free to 
contact Maree Ryan, Lecturer in Voice, Sydney Conservatorium of Music, by telephone on (02) 9351 1259 
or by email at TUmryan@greenway.usyd.edu.au UT or Associate Professor Dianna Kenny by telephone on (02) 
9351 1386 or by email at TUd.kenny@fhs.usyd.edu.auUT  
 
This information sheet is for you to keep. 
 
Any person with concerns or complaints about the conduct of this research can contact the 
Manager for Ethics Administration at The University of Sydney on (02) 9351 4811. 
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The University of Sydney 
 
SYDNEY CONSERVATORIUM  
OF MUSIC 
 
AUSTRALIAN CENTRE FOR APPLIED RESEARCH IN MUSIC 
PERFORMANCE 
 
 
 
 
 
 
 
RESEARCH STUDY 
 
Hormonal influences on the female 
singing voice 
 
 
 
STRUCTURED DIARY FOR SINGERS 
 
Please record your temperature each day upon rising for 
every day of your cycle on the temperature chart 
provided (see chart for detailed instructions)  
 
Please complete each diary page in this booklet at the 
same time each day, preferably towards the END OF 
THE WORKING DAY. There is one page for each day 
over the FOUR-week period  
 
Any concerns or questions, please phone  
Maree Ryan          02 9351 1259 
Dianna Kenny       02 9351 9644 
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For how many years have you been studying singing?  
_______     years 
What is your voice type?______________ 
How old are you?_______ 
Are you pregnant?  YES        ΝΟ    
Are your menstrual cycles regular? 
                                        YES        ΝΟ    
What is your usual cycle length? ________   days 
Do you currently take the oral contraceptive pill? 
              YES        ΝΟ    
DATE: ______________________  ID:____________               Male    Female    
 
 
Below is a list of feelings that people have.  
For each feeling, cross UONE U number for the answer that  
best describes HOW YOU ARE FEELING URIGHT NOW U.  
 
The numbers refer to these phrases   
0 = Not at all,  1 = A little,  2 = Moderately,  3 = Quite a lot,  
4 = Very 
 
Relaxed (0) (1) (2) (3) (4) 
Discouraged (0) (1) (2) (3) (4) 
Annoyed / 
Irritable (0) (1) (2) (3) (4) 
Sad/depressed (0) (1) (2) (3) (4) 
Unable to  
Concentrate (0) (1) (2) (3) (4) 
Energetic (0) (1) (2) (3) (4) 
Forgetful 
/confused  (0) (1) (2) (3) (4) 
Tense/anxious (0) (1) (2) (3) (4) 
Exhausted (0) (1) (2) (3) (4) 
Cheerful (0) (1) (2) (3) (4)  
Angry  (0) (1) (2) (3) (4) 
Fatigued (0) (1) (2) (3) (4) 
Happy  (0) (1) (2) (3) (4) 
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Thinking about your singing UtodayU, to what extent do you agree or disagree with the following: 
 
     Strongly agree          Strongly disagree 
My voice felt in peak form   ___________________________________ 
My voice felt fatigued    ___________________________________ 
It took a lot of effort to sing   ___________________________________ 
My ability to support my sound was affected ___________________________________ 
My voice seemed hoarse or husky  ___________________________________ 
My voice felt muffled, weak or breathy  ___________________________________ 
I could not extend to the top of my range ___________________________________ 
I was not able to control my voice as easily ___________________________________ 
My voice felt “sluggish”   ___________________________________ 
My voice sounded flat in pitch   ___________________________________ 
 
 
 
UTODAYU, DID YOU:  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
     not at all severe                       very severe 
experience cramps?        NO___YES___    ___________________________________ 
feel fatigued?          NO___YES___    ___________________________________ 
feel nauseous?          NO___YES___    ___________________________________ 
feel bloated? (eg breasts?)       NO___YES___    ___________________________________ 
experience food cravings?        NO___YES___    ___________________________________ 
(change in appetite) 
have headaches?         NO___YES___    ___________________________________ 
feel dizzy?          NO___YES___    ___________________________________ 
have difficulty sleeping last night?   NO___YES___    ___________________________________ 
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The University of Sydney 
 
SYDNEY CONSERVATORIUM  
OF MUSIC 
 
AUSTRALIAN CENTRE FOR APPLIED RESEARCH IN MUSIC 
PERFORMANCE 
 
 
 
Maree Ryan  
Lecturer in Voice 
 
 
Sunday, 23 May 2004 
 
 
 
 
Dear xxxx 
 
I am writing to you to invite you to take part in a study at the Australian Centre for Applied 
Research in Music Performance, University of Sydney. The study is about the effect of hormonal 
changes on the sound qualities of the young female singer’s voice.  
 
You have been selected for this project as a singer who demonstrates vocal changes associated 
with your menstrual cycle. The objective is to investigate acoustical and perceptual analysis 
variances when the singer is at certain times in her cycle. 
 
Enclosed are copies of the Information Sheet about the study and the Consent Sheet.  
 
Please do not hesitate to contact me for further information on this project.   
I look forward to speaking with you soon. 
  
Yours sincerely 
 
 
 
Maree Ryan 
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Australian Centre for Applied Research in Music Performance 
The University of Sydney 
 
 
RESEARCH STUDY INTO THE EFFECT OF HORMONAL CHANGES 
ON THE YOUNG FEMALE SINGER 
 
CONSENT SHEET 
 
Project Title:  The Effect of Hormonal Changes on the Young Female Singer 
 
Investigators: Ms Maree Ryan 
     Associate Professor Dianna Kenny 
 
 
1. I acknowledge that I have read the appended information sheet, which explains the nature, 
objective and the possible risks of the investigation, and the statement has been explained to me to 
my satisfaction. Before signing this document I have been given the opportunity to ask questions 
relating to any possible physical harm I may suffer as a result of my participation and I have 
received satisfactory answers. I have also been informed that I may not receive any benefits from 
participating in this study. I have been offered a debriefing session after the research has been 
completed. 
 
2. My decision whether or not to participate will not prejudice my future relations with Australian 
Centre for Applied Research in Music Performance or any of the investigators listed above. If I 
decide to participate, I am free to withdraw my consent and to discontinue participation at any time 
without prejudice. 
 
3. I agree that research data gathered from the results of the study may be published provided my 
name is not used. 
 
 
__________                                _________________________________ 
DATE     Signature of Subject  
 
4. I have fully explained to the subject _______________________________ the nature and 
purpose of the program and the procedures to be employed and such risks as are involved in their 
performance. 
 
 
 
__________                                _________________________________ 
DATE     Signature of Responsible Investigator 
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The University of Sydney 
 
SYDNEY CONSERVATORIUM  
OF MUSIC 
 
AUSTRALIAN CENTRE FOR APPLIED RESEARCH IN MUSIC 
PERFORMANCE 
 
 
 
 
PERCEPTUAL ANALYSIS OF SINGING 
 
 
There are two recordings of your singing, each of twenty (20) seconds duration.  
 
Listen to each recording and indicate by circling either ‘Recording 1’ or ‘Recording 2’ below, which one is better 
in overall quality. If you think the two recordings are of equal quality, please circle the word ‘Equal’.  
 
Recording 1   Recording 2   Equal 
  
Then rate the recording you have chosen, for the following characteristics, by placing a vertical line on the scale 
below: 
 
Example: 
 
 very low quality ____________________________________________________   very high quality 
                  
pitch insecurity _____________________________________________________   pitch security 
 
more breathy _____________________________________________________   less breathy 
 
unsteady _____________________________________________________   steady 
 
more effort _____________________________________________________   less effort  
 
 less supported _____________________________________________________   more supported 
  
 
Recording chosen: 
  
very low quality _____________________________________________________   very high quality 
                  
pitch security _____________________________________________________   pitch insecurity 
 
more breathy _____________________________________________________   less breathy 
 
unsteady _____________________________________________________   steady 
 
more effort _____________________________________________________   less effort  
 
 less supported _____________________________________________________   more supported 
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Australian Centre for Applied Research in Music Performance 
The University of Sydney 
 
 
RESEARCH STUDY INTO THE EFFECT OF HORMONAL CHANGES 
ON THE VOCAL QUALITY OF YOUNG FEMALE SINGERS 
 
 
SINGER SUBJECT FEEDBACK SHEET 
 
 
 
 
Below are a number of statements about your singing voice quality. Please rate your 
agreement or disagreement with each statement by placing a horizontal mark on the scale 
below. 
 
For example …… 
 
I felt happy with my singing today 
 
Strongly disagree Strongly agreeI felt happy with my 
singing today 
 
 
The mark to the right of the centre of the line indicates that this singer was agreed (but not 
strongly) that she felt happy with her singing voice today 
 
The rating scales begin on the next page.
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Excerpt 1: scales 
 
Please rate how you perceived your voice during this singing sample on the following items: 
 
Strongly disagree Strongly agree My voice felt in      
peak form 
 
  
Strongly disagree Strongly agree 
My voice felt fatigued 
 
 
Strongly disagree Strongly agree It took a lot of effort   
to sing 
 
  
Strongly disagree Strongly agree My ability to support 
my sound was affected 
 
 
Strongly disagree Strongly agree My voice seemed 
hoarse or husky 
 
  
Strongly disagree Strongly agree My voice felt muffled, 
weak or breathy 
 
 
Strongly disagree Strongly agree I could extend to the 
top of my range 
 
  
Strongly disagree Strongly agree I was able to control 
my voice easily 
 
 
Strongly disagree Strongly agree My voice felt 
“sluggish” 
 
  
Strongly disagree Strongly agree My voice sounded    
flat in pitch 
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Excerpt 2: “O mio babbino caro” 
 
Please rate how you perceived your voice during this singing sample on the following items: 
 
Strongly disagree Strongly agree My voice felt in      
peak form 
 
  
Strongly disagree Strongly agree 
My voice felt fatigued 
 
 
Strongly disagree Strongly agree It took a lot of effort   
to sing 
 
  
Strongly disagree Strongly agree My ability to support 
my sound was affected 
 
 
Strongly disagree Strongly agree My voice seemed 
hoarse or husky 
 
  
Strongly disagree Strongly agree My voice felt muffled, 
weak or breathy 
 
 
Strongly disagree Strongly agree I could extend to the 
top of my range 
 
  
Strongly disagree Strongly agree I was able to control 
my voice easily 
 
 
Strongly disagree Strongly agree My voice felt 
“sluggish” 
 
  
Strongly disagree Strongly agree My voice sounded    
flat in pitch 
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The University of Sydney 
 
SYDNEY CONSERVATORIUM  
OF MUSIC  
 
 
A/Professor Dianna Kenny 
Australian Centre for Applied Research in Music Performance 
 
SUBJECT INFORMATION SHEET ( UPedagogueU) 
 
RESEARCH STUDY INTO EFFECTS OF THE HORMONAL CYCLE ON THE HUMAN VOICE 
 
You are invited to take part in a research project into the effects of hormonal fluctuation on the 
singing voice. UBoth female (subjects) and male (controls) students will be recruited for this 
research study to be known as the “Effect of Premenstrual Symptoms on Singers”.U 
 
The aim is to investigate the variability of the singing voice due to the effect of certain conditions 
relevant to professional singers. Any adverse effect on the voice that changes quality, ease of 
production and range can cause anxiety in a singer and have an adverse effect on confidence and 
ultimately career. 
 
The study is being conducted by Ms Maree Ryan, full time lecturer in voice at the Sydney 
Conservatorium of Music, under the supervision of Associate Professor Dianna Kenny from the 
Australian Centre for Applied Research in Music Performance. It forms the basis of a Masters 
Degree by Research and meets the ethics requirements of The University of Sydney into research 
with human subjects. 
 
If you agree to participate in this study, you will be asked to Ulisten to tape-recorded vocal excerpts 
from the female (subjects) students during different phases of their menstrual cycle to ascertain if 
you can perceive any differences in their voices on those occasions.U UEach singer will present two 
(2) separate recordings and you will not be told from which part of the cycle each recording is 
taken.U There are no risks involved in this research which will be carried out at the Sydney 
Conservatorium of Music in a staff singing studio. 
 
All collected data from the study will be strictly confidential and only Maree Ryan and Associate 
Professor Dianna Kenny will have direct access to information about the participants. A report of 
the study may be submitted for publication but individual participants will not be able to be 
identified from such a report. Only an allocated number will identify each subject Uand each 
pedagogueU and information will be stored in a locked area within the University premises until it is 
destroyed at the completion of the mandatory storage period of seven (7) years. 
 
Participation in this study is entirely voluntary and Uthere is no remuneration involved. 
 
When you have read this information Maree Ryan will be happy to discuss it with you further and 
answer any questions that you may have about the study. If you would like to know more at any 
stage, please feel free to contact Maree Ryan, Lecturer in Voice, Sydney Conservatorium of Music, 
by telephone on (02) 9351 1259 or by email at TUmryan@greenway.usyd.edu.au UT or Associate 
Professor Dianna Kenny by telephone on (02) 9351 1386 or by email at TUd.kenny@fhs.usyd.edu.auUT  
 
This information sheet is for you to keep. 
 
Any person with concerns or complaints about the conduct of this research can contact the 
Manager for Ethics Administration at The University of Sydney on (02) 9351 4811. 
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The University of Sydney 
 
SYDNEY CONSERVATORIUM  
OF MUSIC 
 
AUSTRALIAN CENTRE FOR APPLIED RESEARCH IN MUSIC 
PERFORMANCE 
 
 
 
PERCEPTUAL ANALYSIS OF SINGING 
 
There are fifteen (15) singing samples in the CD, each of twenty (20) seconds duration. The excerpts are presented 
in random order. We would like you to  
1. rate each sample for overall quality of voice, by placing a vertical line on the scale below; 
2. on the line beneath, explain how you would describe the sound, e.g. Breathy, unsteady. etc: 
 
Sample example: 
   _____________________________________________________ 
  
Very low quality         Very high quality 
 
Breathy, unsteady, etc. 
…………………………………………………………………………………………………………...  
 
 
Sample 1:  _____________________________________________________ 
 
 Very low quality         Very high quality 
 
……………………………………………………………………………………………………………...  
 
 
Sample 2:  _____________________________________________________ 
 
 Very low quality         Very high quality 
 
……………………………………………………………………………………………………………...  
 
 
Sample 3:  _____________________________________________________ 
 
 Very low quality         Very high quality 
 
……………………………………………………………………………………………………………...  
 
 
Sample 4:  _____________________________________________________ 
 
 Very low quality         Very high quality 
 
……………………………………………………………………………………………………………...  
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Sample 5:  _____________________________________________________ 
 
 Very low quality         Very high quality 
 
……………………………………………………………………………………………………………...  
 
 
Sample 6:  _____________________________________________________ 
 
 Very low quality         Very high quality 
 
……………………………………………………………………………………………………………...  
 
 
Sample 7:  _____________________________________________________ 
 
 Very low quality         Very high quality 
 
……………………………………………………………………………………………………………...  
 
 
Sample 8:  _____________________________________________________ 
 
 Very low quality         Very high quality 
 
……………………………………………………………………………………………………………...  
 
 
Sample 9:  _____________________________________________________ 
 
 Very low quality         Very high quality 
 
……………………………………………………………………………………………………………...  
 
 
Sample 10:  _____________________________________________________ 
 
 Very low quality         Very high quality 
 
……………………………………………………………………………………………………………...  
 
 
Sample 11:  _____________________________________________________ 
 
 Very low quality         Very high quality 
 
……………………………………………………………………………………………………………...  
 
 
Sample 12:  _____________________________________________________ 
 
 Very low quality         Very high quality 
……………………………………………………………………………………………………………...  
 
 
Sample 13:  _____________________________________________________ 
 
 Very low quality         Very high quality 
 
……………………………………………………………………………………………………………...  
  130
 
Sample 14:  _____________________________________________________ 
 
 Very low quality         Very high quality 
 
……………………………………………………………………………………………………………...  
Sample 15:  _____________________________________________________ 
 
 Very low quality         Very high quality 
 
……………………………………………………………………………………………………………...  
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Appendix 2 
 
Voice quality by regular cycle or using an oral contraceptive 
 
T-Test 
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Independent Samples Test
.472 .500 -1.401 19 .177 -1.9015 1.35727 -4.74227 .93933
-1.120 3.736 .330 -1.9015 1.69807 -6.75056 2.94762
.067 .798 -1.409 19 .175 -2.000 1.4192 -4.9705 .9705
-1.245 4.022 .281 -2.000 1.6070 -6.4522 2.4522
1.579 .224 -.904 19 .377 -1.424 1.5746 -4.7191 1.8720
-.651 3.515 .555 -1.424 2.1851 -7.8354 4.9883
.960 .340 -.540 19 .596 -.850 1.5751 -4.1466 2.4466
-.405 3.595 .708 -.850 2.0980 -6.9433 5.2433
.041 .842 -1.408 19 .175 -2.403 1.7061 -5.9740 1.1681
-1.289 4.147 .265 -2.403 1.8644 -7.5077 2.7018
.131 .722 -.399 19 .694 -.704 1.7654 -4.3994 2.9906
-.357 4.070 .739 -.704 1.9707 -6.1391 4.7303
.814 .378 -.478 19 .638 -.949 1.9825 -5.0980 3.2010
-.400 3.856 .710 -.949 2.3696 -7.6254 5.7284
.405 .532 -.946 19 .356 -1.690 1.7861 -5.4280 2.0486
-.764 3.763 .490 -1.690 2.2102 -7.9816 4.6022
.714 .409 -1.155 19 .262 -2.071 1.7920 -5.8213 1.6802
-.901 3.677 .423 -2.071 2.2977 -8.6770 4.5358
7.732 .012 -1.415 19 .173 -2.438 1.7228 -6.0441 1.1677
-.945 3.388 .407 -2.438 2.5793 -10.1392 5.2627
Equal variances
assumed
Equal variances
not assumed
Equal variances
assumed
Equal variances
not assumed
Equal variances
assumed
Equal variances
not assumed
Equal variances
assumed
Equal variances
not assumed
Equal variances
assumed
Equal variances
not assumed
Equal variances
assumed
Equal variances
not assumed
Equal variances
assumed
Equal variances
not assumed
Equal variances
assumed
Equal variances
not assumed
Equal variances
assumed
Equal variances
not assumed
Equal variances
assumed
Equal variances
not assumed
Peak_form_r
fatigued voice
effort
support
hoarse
weak
range
control
sluggish
pitch
F Sig.
Levene's Test for
Equality of Variances
t df Sig. (2-tailed)
Mean
Difference
Std. Error
Difference Lower Upper
95% Confidence
Interval of the
Difference
t-test for Equality of Means
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T-Test 
Group Statistics
12 3.5083 2.91687 .84203
9 4.9222 1.62694 .54231
12 3.375 3.0404 .8777
9 5.111 1.5688 .5229
12 3.592 3.2324 .9331
9 4.667 2.1857 .7286
12 2.850 2.6273 .7584
9 5.389 2.3950 .7983
12 4.075 3.1915 .9213
9 6.922 2.3467 .7822
12 4.725 3.2589 .9408
9 5.822 2.9651 .9884
12 3.708 3.5124 1.0140
9 6.589 2.8799 .9600
12 3.517 3.4769 1.0037
9 5.911 2.3197 .7732
12 3.758 3.5426 1.0227
9 5.667 2.6144 .8715
12 5.525 3.6262 1.0468
9 7.389 2.2178 .7393
Take oral contr pill
No
Yes
No
Yes
No
Yes
No
Yes
No
Yes
No
Yes
No
Yes
No
Yes
No
Yes
No
Yes
Peak_form_r
fatigued voice
effort
support
hoarse
weak
range
control
sluggish
pitch
N Mean Std. Deviation
Std. Error
Mean
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Independent Samples Test
4.525 .047 -1.305 19 .208 -1.4139 1.08374 -3.68218 .85441
-1.412 17.806 .175 -1.4139 1.00156 -3.51973 .69195
10.407 .004 -1.558 19 .136 -1.736 1.1145 -4.0688 .5966
-1.699 17.213 .107 -1.736 1.0217 -3.8896 .4174
6.551 .019 -.859 19 .401 -1.075 1.2519 -3.6953 1.5453
-.908 18.862 .375 -1.075 1.1839 -3.5541 1.4041
.001 .980 -2.274 19 .035 -2.539 1.1166 -4.8759 -.2019
-2.306 18.184 .033 -2.539 1.1012 -4.8507 -.2271
2.617 .122 -2.253 19 .036 -2.847 1.2639 -5.4926 -.2018
-2.356 19.000 .029 -2.847 1.2086 -5.3768 -.3176
.563 .462 -.793 19 .438 -1.097 1.3840 -3.9939 1.7995
-.804 18.198 .432 -1.097 1.3645 -3.9617 1.7673
3.851 .065 -2.003 19 .060 -2.881 1.4380 -5.8903 .1292
-2.063 18.795 .053 -2.881 1.3963 -5.8052 .0441
5.622 .028 -1.784 19 .090 -2.394 1.3422 -5.2036 .4148
-1.890 18.818 .074 -2.394 1.2670 -5.0481 .2592
1.609 .220 -1.359 19 .190 -1.908 1.4044 -4.8478 1.0311
-1.420 19.000 .172 -1.908 1.3436 -4.7205 .9039
3.536 .075 -1.358 19 .190 -1.864 1.3722 -4.7360 1.0082
-1.454 18.411 .163 -1.864 1.2815 -4.5520 .8242
Equal variances
assumed
Equal variances
not assumed
Equal variances
assumed
Equal variances
not assumed
Equal variances
assumed
Equal variances
not assumed
Equal variances
assumed
Equal variances
not assumed
Equal variances
assumed
Equal variances
not assumed
Equal variances
assumed
Equal variances
not assumed
Equal variances
assumed
Equal variances
not assumed
Equal variances
assumed
Equal variances
not assumed
Equal variances
assumed
Equal variances
not assumed
Equal variances
assumed
Equal variances
not assumed
Peak_form_r
fatigued voice
effort
support
hoarse
weak
range
control
sluggish
pitch
F Sig.
Levene's Test for
Equality of Variances
t df Sig. (2-tailed)
Mean
Difference
Std. Error
Difference Lower Upper
95% Confidence
Interval of the
Difference
t-test for Equality of Means
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Appendix 3 
 
Temperature and day of cycle 
 
 
 
1114561015181920212121202021212021212022222122222222222222222222N =
SEX= Female
day of cycle
3533312927252321191715131197531
cy
cl
e_
da
y1
37.5
37.0
36.5
36.0
35.5
35.0
34.5
708
673
524672
707
523671
706517
700
661
658
693
692
255
651
445
335
249
561
385
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Temperature and oral contraception 
 
  Cycle 1   Cycle 2  
  Taking 
pill 
Temp 
rise 
 Taking 
pill 
Temp 
rise 
ID No       
1  no yes  no yes 
2 male       
3  no yes  no no 
4 ■ no ?  no ? 
5       
6 male       
7  yes no  yes no 
8  yes yes  yes yes 
9       
10  no yes  no no 
11 ■ no yes  no yes 
12  yes yes  yes yes 
13  no yes  no yes 
14 male       
15 male       
16  no no  yes no 
17  yes no    
18  no no  no no 
19  no no  no no 
20  ? yes  no yes 
21 ■ no yes  no yes 
22 ■ no ?  yes no 
23       
24 ■ yes no  no yes 
25  yes no    
26  yes yes  yes no 
27 ■ yes yes  no yes 
28  no yes  no no 
29  yes yes  yes ? 
30 male       
31 male       
 
■ most affected females 
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Appendix 4 
 
Voice quality by day in females 
 
 
Peak_form_r 
345913161418181919211719212120202021211621222021212120212021N =
SEX= Female
day of cycle
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fatigued voice 
345913161418181919211719212120202021211621222021212120212021N =
SEX= Female
day of cycle
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effort 
345913161418181919211719212120202021211621222021212120212021N =
SEX= Female
day of cycle
312927252321191715131197531
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support 
345913161418181919211719212120202021211621222021212120212021N =
SEX= Female
day of cycle
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hoarse 
345913161418181919211719212120202021211621222021212120212021N =
SEX= Female
day of cycle
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weak 
345913161418181919211719212120202021211621222021212120212021N =
SEX= Female
day of cycle
312927252321191715131197531
w
ea
k
12
10
8
6
4
2
0
-2
501215269
 
range 
345913161418181919211719212120202021211621222021212120212021N =
SEX= Female
day of cycle
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control 
345913161418181919211719212120202021211621222021212120212021N =
SEX= Female
day of cycle
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261714
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sluggish 
345913161418181919211719212120202021211621222021212120212021N =
SEX= Female
day of cycle
312927252321191715131197531
sl
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0
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pitch 
345913161418181919211719212120202021211621222021212120212021N =
SEX= Female
day of cycle
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Appendix 5 
 
Voice quality by day in males 
 
Peak form 
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SEX= Male
day of cycle
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fatigued voice 
5456556656655666666645555566N =
SEX= Male
day of cycle
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effort 
5456556656655666666645555566N =
SEX= Male
day of cycle
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support 
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hoarse 
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weak 
5456556656655666666645555566N =
SEX= Male
day of cycle
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range 
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control 
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sluggish 
5456556656655666666645555566N =
SEX= Male
day of cycle
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pitch 
5456556656655666666645555566N =
SEX= Male
day of cycle
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Appendix 6 
 
Kendall’s correlation between VAS scores and voice quality by day in females 
 
 
DAY 1  Cramps Fatigue Nauseous Bloated Cravings Headaches Dizzy Sleeping
Peak form Kendalls -0.01 -0.07 -0.32 -0.33 -0.16 0.20 -0.32 -0.31
 Pvalue 0.97 0.72 0.09 0.08 0.40 0.28 0.09 0.10
fatigued 
voice 
Kendalls -0.02 -0.13 -0.25 -0.16 0.01 0.23 -0.32 -0.19
 Pvalue 0.93 0.47 0.18 0.39 0.97 0.22 0.09 0.30
effort Kendalls -0.08 -0.12 -0.10 -0.34 0.00 0.16 -0.20 -0.33
 Pvalue 0.68 0.51 0.60 0.07 1.00 0.39 0.29 0.08
support Kendalls -0.23 -0.31 -0.20 -0.48 -0.06 0.16 -0.31 -0.25
 Pvalue 0.22 0.09 0.28 0.01 0.75 0.39 0.10 0.18
hoarse Kendalls -0.17 -0.33 -0.14 -0.19 0.08 0.15 -0.26 -0.11
 Pvalue 0.36 0.08 0.46 0.32 0.67 0.43 0.17 0.55
weak Kendalls -0.08 -0.26 0.06 -0.23 0.07 0.16 -0.01 -0.25
 Pvalue 0.68 0.17 0.74 0.23 0.70 0.41 0.94 0.18
range Kendalls 0.03 -0.10 0.02 -0.29 0.05 0.40 0.09 -0.11
 Pvalue 0.87 0.59 0.91 0.13 0.80 0.03 0.62 0.54
control Kendalls -0.02 -0.15 -0.20 -0.35 -0.07 0.43 -0.13 -0.19
 Pvalue 0.90 0.44 0.30 0.06 0.72 0.02 0.50 0.30
sluggish Kendalls -0.47 -0.25 -0.17 -0.31 0.15 0.12 -0.01 -0.35
 Pvalue 0.01 0.19 0.37 0.10 0.42 0.51 0.97 0.06
pitch Kendalls -0.41 0.11 -0.15 -0.16 0.01 -0.22 -0.01 0.05
 Pvalue 0.03 0.55 0.41 0.39 0.97 0.25 0.94 0.80
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DAY 3  Cramps Fatigue Nauseous Bloated Cravings Headaches Dizzy Sleeping
Peak form Kendalls 0.12 -0.52 -0.06 -0.13 -0.04 -0.09 0.01 -0.21
 Pvalue 0.53 0.01 0.74 0.48 0.82 0.63 0.96 0.26
fatigued voice Kendalls 0.25 -0.26 -0.13 0.21 0.09 -0.17 0.03 -0.11
 Pvalue 0.19 0.17 0.51 0.27 0.63 0.37 0.89 0.57
effort Kendalls 0.15 -0.28 -0.22 0.33 0.19 -0.01 -0.01 -0.09
 Pvalue 0.43 0.13 0.25 0.08 0.31 0.97 0.96 0.63
support Kendalls -0.08 -0.20 -0.23 0.15 0.01 -0.11 -0.11 -0.11
 Pvalue 0.65 0.29 0.21 0.44 0.94 0.58 0.56 0.58
hoarse Kendalls 0.08 0.20 0.12 0.31 0.28 0.21 0.22 0.15
 Pvalue 0.68 0.28 0.51 0.09 0.14 0.26 0.24 0.43
weak Kendalls 0.08 -0.03 -0.28 0.14 0.08 -0.09 0.03 -0.13
 Pvalue 0.68 0.88 0.14 0.46 0.68 0.63 0.86 0.48
range Kendalls -0.15 -0.06 -0.03 0.25 0.12 0.12 0.15 -0.10
 Pvalue 0.43 0.75 0.87 0.20 0.52 0.52 0.44 0.60
control Kendalls 0.04 -0.25 -0.16 0.34 0.19 0.06 0.02 -0.08
 Pvalue 0.82 0.19 0.41 0.07 0.31 0.77 0.93 0.65
sluggish Kendalls 0.08 -0.29 -0.25 0.21 0.06 0.01 -0.08 -0.18
 Pvalue 0.68 0.12 0.19 0.26 0.74 0.94 0.65 0.35
pitch Kendalls 0.07 -0.18 0.09 0.42 0.30 0.18 0.08 0.06
 Pvalue 0.71 0.35 0.62 0.03 0.11 0.35 0.69 0.77
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DAY 7  Cramps Fatigue Nauseous Bloated Cravings Headaches Dizzy Sleeping
Peak form Kendalls -0.28 -0.14 -0.23 -0.03 0.41 -0.43 -0.39 -0.23
 Pvalue 0.13 0.46 0.22 0.89 0.03 0.02 0.04 0.23
fatigued voice Kendalls -0.38 -0.07 -0.22 -0.17 0.08 -0.44 -0.16 -0.40
 Pvalue 0.04 0.72 0.25 0.37 0.68 0.02 0.40 0.04
effort Kendalls -0.34 -0.03 -0.17 -0.21 0.37 -0.25 -0.10 -0.35
 Pvalue 0.07 0.89 0.36 0.26 0.05 0.19 0.59 0.06
support Kendalls -0.33 -0.03 -0.14 -0.17 0.43 -0.31 -0.12 -0.36
 Pvalue 0.08 0.89 0.46 0.37 0.02 0.10 0.51 0.06
hoarse Kendalls -0.36 0.01 -0.19 -0.23 0.30 -0.47 -0.25 -0.41
 Pvalue 0.06 0.94 0.32 0.23 0.11 0.01 0.19 0.03
weak Kendalls -0.32 -0.07 -0.12 -0.19 0.23 -0.39 -0.16 -0.29
 Pvalue 0.09 0.70 0.51 0.30 0.23 0.04 0.40 0.12
range Kendalls -0.36 -0.05 -0.19 -0.15 0.48 -0.04 -0.03 -0.32
 Pvalue 0.05 0.78 0.32 0.42 0.01 0.82 0.86 0.09
control Kendalls -0.36 -0.14 -0.19 -0.07 0.42 -0.09 0.02 -0.20
 Pvalue 0.06 0.46 0.32 0.72 0.03 0.62 0.90 0.29
sluggish Kendalls -0.37 -0.01 -0.20 -0.18 0.44 -0.16 -0.19 -0.18
 Pvalue 0.05 0.97 0.28 0.35 0.02 0.39 0.31 0.35
pitch Kendalls -0.43 0.10 -0.28 -0.08 0.29 -0.49 -0.30 -0.09
 Pvalue 0.02 0.59 0.14 0.69 0.13 0.01 0.12 0.64
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DAY 14  Cramps Fatigue Nauseous Bloated Cravings Headaches Dizzy Sleeping
Peak form Kendalls . -0.16 -0.15 . -0.02 -0.37 -0.31 -0.22
 Pvalue . 0.40 0.43 . 0.93 0.06 0.11 0.26
fatigued voice Kendalls . -0.07 0.13 . 0.05 -0.27 -0.12 -0.20
 Pvalue . 0.73 0.49 . 0.79 0.16 0.53 0.31
effort Kendalls . -0.16 0.12 . -0.03 -0.20 -0.15 -0.11
 Pvalue . 0.42 0.54 . 0.86 0.31 0.45 0.56
support Kendalls . -0.17 0.12 . -0.17 -0.19 -0.04 -0.16
 Pvalue . 0.38 0.54 . 0.38 0.33 0.85 0.42
hoarse Kendalls . -0.13 0.02 . 0.08 -0.33 -0.22 -0.18
 Pvalue . 0.52 0.93 . 0.66 0.09 0.25 0.37
weak Kendalls . -0.11 0.03 . 0.15 -0.33 -0.21 -0.17
 Pvalue . 0.57 0.86 . 0.43 0.10 0.28 0.39
range Kendalls . -0.23 0.03 . -0.22 -0.19 -0.21 0.01
 Pvalue . 0.24 0.86 . 0.26 0.34 0.28 0.96
control Kendalls . -0.15 -0.02 . 0.15 -0.31 -0.23 -0.12
 Pvalue . 0.45 0.93 . 0.43 0.11 0.23 0.52
sluggish Kendalls . -0.21 0.05 . -0.05 -0.24 -0.20 -0.07
 Pvalue . 0.27 0.79 . 0.79 0.22 0.31 0.71
pitch Kendalls . -0.15 0.02 . -0.13 -0.28 -0.15 -0.18
 Pvalue . 0.45 0.93 . 0.49 0.15 0.45 0.37
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DAY 18  Cramps Fatigue Nauseous Bloated Cravings Headaches Dizzy Sleeping
Peak form Kendalls 0.07 -0.04 -0.19 -0.19 -0.09 0.00 0.01 0.12
 Pvalue 0.72 0.85 0.31 0.30 0.65 1.00 0.96 0.51
fatigued voice Kendalls 0.06 -0.18 -0.18 -0.20 -0.11 0.03 0.04 -0.16
 Pvalue 0.76 0.35 0.34 0.28 0.55 0.87 0.84 0.40
effort Kendalls 0.00 -0.32 -0.20 -0.04 -0.02 0.02 0.02 -0.15
 Pvalue 1.00 0.09 0.28 0.82 0.92 0.93 0.92 0.44
support Kendalls -0.08 -0.23 -0.24 -0.13 -0.08 -0.05 -0.01 0.01
 Pvalue 0.65 0.22 0.21 0.50 0.65 0.80 0.96 0.95
hoarse Kendalls -0.18 -0.45 -0.29 -0.07 -0.15 -0.12 -0.07 -0.21
 Pvalue 0.34 0.02 0.12 0.72 0.42 0.51 0.72 0.25
weak Kendalls -0.11 -0.24 -0.25 -0.02 -0.09 -0.09 -0.02 -0.20
 Pvalue 0.55 0.20 0.19 0.93 0.61 0.62 0.92 0.28
range Kendalls -0.08 -0.51 -0.22 -0.03 -0.11 -0.06 0.00 -0.19
 Pvalue 0.69 0.01 0.23 0.86 0.55 0.74 1.00 0.31
control Kendalls -0.04 -0.40 -0.25 -0.03 -0.08 -0.06 -0.02 0.02
 Pvalue 0.84 0.03 0.19 0.86 0.69 0.74 0.92 0.90
sluggish Kendalls -0.18 -0.17 -0.33 0.16 0.11 -0.14 -0.09 0.03
 Pvalue 0.34 0.37 0.08 0.39 0.55 0.46 0.61 0.86
pitch Kendalls -0.17 -0.32 -0.32 0.03 0.02 -0.12 -0.09 -0.16
 Pvalue 0.36 0.09 0.09 0.86 0.92 0.51 0.65 0.40
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Appendix 7 
 
Kendall’s correlation between mood and voice quality by day in females – part 1 
 
DAY 1  Relaxed Discouraged Annoyed Sad Concentrate Energetic Forgetful Tense
Peak form Kendalls -0.23 -0.31 -0.44 -0.28 -0.34 -0.17 -0.35 -0.35
 Pvalue 0.18 0.08 0.01 0.10 0.06 0.34 0.05 0.04
fatigued voice Kendalls -0.14 -0.41 -0.36 -0.27 -0.34 -0.04 -0.39 -0.33
 Pvalue 0.42 0.02 0.04 0.12 0.06 0.82 0.03 0.06
effort Kendalls -0.13 -0.24 -0.12 -0.03 -0.30 -0.03 -0.39 -0.31
 Pvalue 0.45 0.17 0.50 0.85 0.09 0.87 0.03 0.07
support Kendalls -0.26 -0.42 -0.27 -0.26 -0.39 -0.24 -0.44 -0.32
 Pvalue 0.13 0.02 0.12 0.13 0.03 0.17 0.01 0.06
hoarse Kendalls -0.26 -0.39 -0.26 -0.30 -0.36 -0.10 -0.33 -0.09
 Pvalue 0.13 0.03 0.13 0.08 0.04 0.59 0.06 0.59
weak Kendalls -0.18 -0.38 -0.28 -0.30 -0.33 -0.10 -0.36 -0.22
 Pvalue 0.30 0.03 0.11 0.08 0.06 0.59 0.04 0.20
range Kendalls -0.13 -0.28 -0.29 -0.18 -0.15 0.02 -0.19 -0.09
 Pvalue 0.45 0.10 0.10 0.31 0.41 0.92 0.28 0.61
control Kendalls -0.25 -0.39 -0.39 -0.29 -0.23 -0.06 -0.25 -0.27
 Pvalue 0.15 0.02 0.03 0.09 0.20 0.72 0.16 0.12
sluggish Kendalls -0.49 -0.55 -0.48 -0.35 -0.44 -0.35 -0.46 -0.36
 Pvalue 0.00 0.00 0.01 0.04 0.01 0.04 0.01 0.04
pitch Kendalls -0.43 -0.49 -0.44 -0.35 -0.35 -0.45 -0.34 -0.21
 Pvalue 0.01 0.00 0.01 0.04 0.05 0.01 0.05 0.22
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DAY 3  Relaxed Discouraged Annoyed Sad Concentrate Energetic Forgetful Tense
Peak form Kendalls -0.28 -0.12 0.07 -0.22 -0.12 -0.29 -0.33 -0.11
 Pvalue 0.11 0.50 0.72 0.22 0.49 0.10 0.07 0.54
fatigued voice Kendalls -0.56 -0.23 -0.27 -0.56 -0.10 -0.09 -0.22 -0.39
 Pvalue 0.00 0.19 0.14 0.00 0.57 0.59 0.23 0.02
effort Kendalls -0.43 -0.39 -0.41 -0.48 -0.19 0.02 -0.26 -0.37
 Pvalue 0.01 0.03 0.02 0.01 0.28 0.90 0.14 0.03
support Kendalls -0.46 -0.60 -0.56 -0.47 -0.33 0.11 -0.34 -0.38
 Pvalue 0.01 0.00 0.00 0.01 0.06 0.53 0.06 0.03
hoarse Kendalls -0.36 -0.42 -0.34 -0.32 -0.11 -0.03 -0.27 -0.19
 Pvalue 0.04 0.02 0.05 0.07 0.53 0.85 0.13 0.28
weak Kendalls -0.63 -0.56 -0.62 -0.54 -0.23 0.10 -0.31 -0.56
 Pvalue 0.00 0.00 0.00 0.00 0.18 0.55 0.09 0.00
range Kendalls -0.44 -0.63 -0.50 -0.54 -0.26 0.00 -0.44 -0.43
 Pvalue 0.01 0.00 0.01 0.00 0.14 1.00 0.01 0.01
control Kendalls -0.44 -0.47 -0.46 -0.57 -0.28 -0.03 -0.32 -0.41
 Pvalue 0.01 0.01 0.01 0.00 0.11 0.88 0.08 0.02
sluggish Kendalls -0.44 -0.36 -0.46 -0.48 -0.19 -0.05 -0.29 -0.46
 Pvalue 0.01 0.04 0.01 0.01 0.27 0.78 0.11 0.01
pitch Kendalls -0.33 -0.42 -0.28 -0.43 -0.06 0.04 -0.40 -0.25
 Pvalue 0.06 0.02 0.12 0.02 0.73 0.80 0.03 0.16
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DAY 7  Relaxed Discouraged Annoyed Sad Concentrate Energetic Forgetful Tense
Peak form Kendalls -0.31 -0.12 -0.14 0.02 -0.30 -0.35 -0.13 -0.24
 Pvalue 0.07 0.48 0.42 0.90 0.08 0.05 0.46 0.17
fatigued voice Kendalls 0.20 -0.07 0.00 0.06 -0.14 -0.04 0.02 -0.04
 Pvalue 0.24 0.70 1.00 0.72 0.44 0.82 0.92 0.82
effort Kendalls -0.09 -0.28 -0.40 -0.17 -0.35 -0.14 -0.37 -0.42
 Pvalue 0.59 0.10 0.02 0.33 0.05 0.43 0.04 0.02
support Kendalls -0.11 -0.28 -0.35 -0.07 -0.34 -0.16 -0.35 -0.36
 Pvalue 0.51 0.10 0.05 0.67 0.05 0.36 0.06 0.04
hoarse Kendalls -0.07 -0.25 -0.20 -0.11 -0.32 -0.23 -0.23 -0.21
 Pvalue 0.68 0.15 0.26 0.54 0.07 0.20 0.20 0.23
weak Kendalls -0.06 -0.26 -0.34 -0.04 -0.35 -0.14 -0.34 -0.25
 Pvalue 0.71 0.13 0.06 0.82 0.05 0.43 0.06 0.16
range Kendalls -0.08 -0.40 -0.46 -0.29 -0.31 -0.08 -0.35 -0.44
 Pvalue 0.64 0.02 0.01 0.09 0.08 0.65 0.06 0.01
control Kendalls -0.03 -0.33 -0.53 -0.11 -0.30 0.13 -0.42 -0.48
 Pvalue 0.85 0.06 0.00 0.54 0.08 0.47 0.02 0.01
sluggish Kendalls -0.14 -0.31 -0.44 -0.02 -0.15 -0.02 -0.43 -0.42
 Pvalue 0.43 0.07 0.01 0.90 0.40 0.92 0.02 0.02
pitch Kendalls -0.00 -0.07 -0.11 -0.16 -0.30 0.04 -0.12 -0.20
 Pvalue 1.00 0.70 0.55 0.36 0.09 0.84 0.52 0.26
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DAY 14  Relaxed Discouraged Annoyed Sad Concentrate Energetic Forgetful Tense
Peak form Kendalls -0.32 -0.42 -0.12 -0.29 0.04 -0.24 0.02 -0.18
 Pvalue 0.08 0.03 0.51 0.12 0.82 0.18 0.91 0.33
fatigued voice Kendalls -0.27 -0.39 -0.26 -0.50 -0.06 -0.24 -0.15 -0.37
 Pvalue 0.14 0.04 0.16 0.01 0.77 0.17 0.42 0.04
effort Kendalls -0.13 -0.35 -0.12 -0.28 -0.07 -0.19 0.08 -0.24
 Pvalue 0.46 0.07 0.54 0.14 0.71 0.27 0.67 0.19
support Kendalls -0.11 -0.28 -0.24 -0.36 -0.11 -0.09 -0.05 -0.18
 Pvalue 0.55 0.14 0.21 0.06 0.58 0.61 0.79 0.33
hoarse Kendalls -0.27 -0.26 -0.02 -0.31 -0.22 -0.18 -0.05 -0.35
 Pvalue 0.13 0.16 0.93 0.09 0.24 0.30 0.79 0.05
weak Kendalls -0.20 -0.27 -0.08 -0.41 -0.06 -0.24 -0.02 -0.33
 Pvalue 0.26 0.15 0.70 0.03 0.74 0.17 0.91 0.07
range Kendalls -0.06 -0.15 -0.43 -0.40 -0.06 -0.05 -0.07 -0.20
 Pvalue 0.73 0.42 0.02 0.03 0.74 0.79 0.73 0.26
control Kendalls -0.09 -0.28 -0.22 -0.49 -0.03 -0.30 -0.12 -0.43
 Pvalue 0.63 0.14 0.26 0.01 0.85 0.09 0.54 0.02
sluggish Kendalls -0.17 -0.40 -0.20 -0.37 -0.09 -0.24 -0.01 -0.31
 Pvalue 0.36 0.03 0.30 0.05 0.63 0.17 0.97 0.09
pitch Kendalls -0.24 -0.42 -0.48 -0.64 0.03 -0.28 -0.16 -0.36
 Pvalue 0.18 0.02 0.01 0.00 0.88 0.11 0.39 0.05
 
 
 154        
 
DAY 18  Relaxed Discouraged Annoyed Sad Concentrate Energetic Forgetful Tense
Peak form Kendalls -0.51 -0.43 -0.27 -0.02 -0.02 -0.28 -0.40 -0.15
 Pvalue 0.00 0.02 0.13 0.91 0.89 0.11 0.03 0.41
fatigued voice Kendalls -0.43 -0.48 -0.20 -0.27 -0.19 -0.43 -0.43 -0.28
 Pvalue 0.02 0.01 0.26 0.14 0.30 0.01 0.02 0.12
effort Kendalls -0.36 -0.42 -0.43 -0.35 -0.27 -0.27 -0.42 -0.28
 Pvalue 0.05 0.02 0.02 0.06 0.14 0.12 0.02 0.13
support Kendalls -0.35 -0.41 -0.42 -0.41 -0.42 -0.18 -0.51 -0.12
 Pvalue 0.05 0.02 0.02 0.03 0.02 0.31 0.00 0.50
hoarse Kendalls -0.25 -0.27 -0.26 -0.40 -0.26 -0.39 -0.31 -0.20
 Pvalue 0.16 0.13 0.15 0.04 0.16 0.03 0.09 0.28
weak Kendalls -0.27 -0.41 -0.28 -0.52 -0.47 -0.32 -0.45 -0.14
 Pvalue 0.13 0.02 0.12 0.01 0.01 0.07 0.01 0.43
range Kendalls -0.21 -0.06 -0.19 -0.11 -0.32 -0.30 -0.22 -0.06
 Pvalue 0.23 0.76 0.29 0.55 0.08 0.09 0.22 0.76
control Kendalls -0.28 -0.32 -0.36 -0.23 -0.43 -0.17 -0.55 -0.30
 Pvalue 0.11 0.08 0.04 0.23 0.02 0.34 0.00 0.10
sluggish Kendalls -0.32 -0.45 -0.43 -0.32 -0.32 0.01 -0.36 -0.17
 Pvalue 0.07 0.01 0.02 0.09 0.08 0.95 0.05 0.36
pitch Kendalls -0.41 -0.29 -0.28 -0.11 -0.09 -0.25 -0.17 -0.04
 Pvalue 0.02 0.12 0.13 0.57 0.61 0.15 0.35 0.81
 
 155        
Appendix 8 
 
Kendall’s correlation between mood and voice quality by day in females – part 2 
 
 
DAY 1 Exhausted Cheerful Angry Fatigued Happy Total mood 
Peak form Kendalls -0.40 -0.10 -0.17 -0.47 -0.18 -0.34
 Pvalue 0.02 0.56 0.35 0.01 0.30 0.03
fatigued voice Kendalls -0.37 -0.14 -0.13 -0.48 -0.16 -0.31
 Pvalue 0.03 0.40 0.49 0.00 0.34 0.05
effort Kendalls -0.37 0.06 -0.11 -0.33 0.08 -0.19
 Pvalue 0.03 0.75 0.56 0.05 0.64 0.24
support Kendalls -0.44 -0.28 -0.14 -0.54 -0.21 -0.36
 Pvalue 0.01 0.11 0.44 0.00 0.22 0.02
hoarse Kendalls -0.34 -0.38 -0.21 -0.42 -0.35 -0.37
 Pvalue 0.04 0.03 0.26 0.01 0.04 0.02
weak Kendalls -0.40 -0.26 -0.21 -0.43 -0.33 -0.35
 Pvalue 0.02 0.14 0.25 0.01 0.05 0.03
range Kendalls -0.35 -0.26 -0.06 -0.40 -0.25 -0.25
 Pvalue 0.04 0.13 0.76 0.02 0.15 0.12
control Kendalls -0.41 -0.39 -0.14 -0.48 -0.28 -0.38
 Pvalue 0.02 0.02 0.46 0.00 0.10 0.02
sluggish Kendalls -0.38 -0.43 -0.30 -0.47 -0.42 -0.50
 Pvalue 0.02 0.01 0.10 0.01 0.01 0.00
pitch Kendalls -0.37 -0.52 -0.31 -0.47 -0.58 -0.49
 Pvalue 0.03 0.00 0.09 0.01 0.00 0.00
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DAY 3 Exhausted Cheerful Angry Fatigued  Happy Total mood 
Peak form Kendalls -0.31 -0.38 0.13 -0.60 -0.36 -0.32
 Pvalue 0.07 0.03 0.49 0.00 0.04 0.05
fatigued voice Kendalls -0.46 -0.46 -0.30 -0.28 -0.28 -0.40
 Pvalue 0.01 0.01 0.10 0.11 0.11 0.01
effort Kendalls -0.44 -0.36 -0.37 -0.22 -0.32 -0.41
 Pvalue 0.01 0.04 0.04 0.19 0.06 0.01
support Kendalls -0.35 -0.30 -0.56 -0.16 -0.26 -0.41
 Pvalue 0.04 0.08 0.00 0.35 0.13 0.01
hoarse Kendalls -0.27 -0.38 -0.32 -0.07 -0.25 -0.35
 Pvalue 0.11 0.03 0.08 0.69 0.15 0.03
weak Kendalls -0.23 -0.32 -0.58 -0.05 -0.21 -0.40
 Pvalue 0.18 0.06 0.00 0.76 0.22 0.01
range Kendalls -0.42 -0.37 -0.43 -0.22 -0.27 -0.48
 Pvalue 0.01 0.03 0.02 0.20 0.12 0.00
control Kendalls -0.46 -0.38 -0.41 -0.24 -0.27 -0.47
 Pvalue 0.01 0.03 0.03 0.16 0.11 0.00
sluggish Kendalls -0.43 -0.32 -0.45 -0.21 -0.26 -0.43
 Pvalue 0.01 0.06 0.01 0.21 0.13 0.01
pitch Kendalls -0.40 -0.29 -0.24 -0.19 -0.23 -0.32
 Pvalue 0.02 0.09 0.19 0.26 0.18 0.05
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DAY 7 Exhausted Cheerful Angry Fatigued Happy Total mood
Peak form Kendalls -0.06 -0.32 -0.13 -0.13 -0.31 -0.29
 Pvalue 0.71 0.06 0.46 0.47 0.07 0.07
fatigued voice Kendalls -0.14 -0.12 -0.05 -0.02 0.07 -0.08
 Pvalue 0.43 0.47 0.77 0.92 0.69 0.63
effort Kendalls -0.16 -0.16 -0.31 -0.13 -0.11 -0.27
 Pvalue 0.34 0.35 0.09 0.45 0.51 0.10
support Kendalls -0.07 -0.18 -0.35 -0.07 -0.09 -0.25
 Pvalue 0.68 0.29 0.05 0.70 0.60 0.12
hoarse Kendalls -0.18 -0.27 -0.31 -0.07 -0.08 -0.24
 Pvalue 0.30 0.12 0.09 0.68 0.64 0.13
weak Kendalls -0.17 -0.23 -0.29 -0.08 -0.02 -0.23
 Pvalue 0.31 0.19 0.11 0.66 0.90 0.15
range Kendalls -0.13 -0.09 -0.19 -0.19 -0.18 -0.31
 Pvalue 0.47 0.59 0.29 0.27 0.30 0.05
control Kendalls -0.03 -0.05 -0.22 -0.11 -0.12 -0.25
 Pvalue 0.85 0.78 0.24 0.53 0.47 0.11
sluggish Kendalls 0.02 -0.15 -0.18 -0.13 -0.29 -0.27
 Pvalue 0.90 0.40 0.33 0.46 0.09 0.09
pitch Kendalls -0.07 -0.07 -0.14 0.04 0.01 -0.10
 Pvalue 0.68 0.68 0.46 0.80 0.95 0.52
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DAY 14 Exhausted Cheerful Angry Fatigued  Happy Total mood
Peak form Kendalls 0.08 -0.48 -0.10 -0.01 -0.50 -0.28
 Pvalue 0.65 0.01 0.61 0.97 0.01 0.10
fatigued voice Kendalls -0.07 -0.39 -0.27 -0.23 -0.41 -0.42
 Pvalue 0.70 0.03 0.16 0.21 0.02 0.01
effort Kendalls 0.05 -0.47 -0.15 -0.17 -0.37 -0.21
 Pvalue 0.78 0.01 0.45 0.34 0.04 0.20
support Kendalls -0.10 -0.44 -0.22 -0.14 -0.28 -0.20
 Pvalue 0.60 0.02 0.25 0.43 0.12 0.24
hoarse Kendalls -0.04 -0.53 -0.27 -0.21 -0.54 -0.31
 Pvalue 0.81 0.00 0.16 0.23 0.00 0.06
weak Kendalls 0.07 -0.52 -0.25 -0.14 -0.47 -0.32
 Pvalue 0.70 0.00 0.21 0.43 0.01 0.06
range Kendalls -0.19 -0.22 -0.27 -0.32 -0.14 -0.24
 Pvalue 0.30 0.23 0.16 0.08 0.43 0.14
control Kendalls -0.08 -0.41 -0.21 -0.23 -0.38 -0.37
 Pvalue 0.65 0.02 0.28 0.20 0.03 0.02
sluggish Kendalls -0.08 -0.47 -0.16 -0.33 -0.38 -0.30
 Pvalue 0.65 0.01 0.41 0.07 0.04 0.07
pitch Kendalls -0.12 -0.46 -0.25 -0.25 -0.40 -0.47
 Pvalue 0.51 0.01 0.21 0.16 0.03 0.00
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DAY 18 Exhausted Cheerful Angry Fatigued Happy Total mood
Peak form Kendalls -0.03 -0.20 -0.34 -0.20 -0.10 -0.29
 Pvalue 0.85 0.25 0.06 0.24 0.55 0.08
fatigued voice Kendalls -0.26 -0.37 -0.25 -0.41 -0.38 -0.50
 Pvalue 0.13 0.03 0.18 0.02 0.03 0.00
effort Kendalls -0.29 -0.35 -0.30 -0.36 -0.33 -0.50
 Pvalue 0.09 0.05 0.10 0.04 0.05 0.00
support Kendalls -0.18 -0.36 -0.37 -0.26 -0.27 -0.46
 Pvalue 0.30 0.04 0.04 0.13 0.11 0.00
hoarse Kendalls -0.34 -0.40 -0.40 -0.20 -0.39 -0.48
 Pvalue 0.05 0.02 0.03 0.24 0.02 0.00
weak Kendalls -0.20 -0.49 -0.26 -0.30 -0.43 -0.56
 Pvalue 0.26 0.00 0.15 0.08 0.01 0.00
range Kendalls -0.41 -0.24 -0.26 -0.14 -0.17 -0.29
 Pvalue 0.02 0.16 0.15 0.43 0.33 0.07
control Kendalls -0.31 -0.33 -0.34 -0.14 -0.25 -0.45
 Pvalue 0.08 0.06 0.06 0.41 0.14 0.01
sluggish Kendalls 0.01 -0.34 -0.19 -0.02 -0.24 -0.34
 Pvalue 0.95 0.05 0.29 0.90 0.16 0.04
pitch Kendalls -0.11 -0.23 -0.28 -0.05 -0.11 -0.25
 Pvalue 0.54 0.19 0.12 0.77 0.53 0.12
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Appendix 9 
 
Relation between voice quality and total mood score in females 
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Appendix 10 
 
Plots of voice quality parameters in females over days 1-7 of the cycle 
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Appendix 11 
 
Plots of mean voice quality over days 1-25 of cycle by gender 
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Appendix 12 
 
Mean-vs- differences plots for mood and voice quality variables 
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Linear Regression
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Hoarse 2-1 = 0.25 + -0.00 * mean_s5
R-Square = 0.00
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Range 2-1 = 1.02 + -0.12 * mean_s7
R-Square = 0.01
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Linear Regression
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Weak 2-1 = 0.66 + -0.05 * mean_s6
R-Square = 0.00
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Control 2-1 = 1.18 + -0.12 * mean_s8
R-Square = 0.01
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Linear Regression
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Sluggish 2-1 = 0.54 + -0.03 * mean_s9
R-Square = 0.00
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Pitch 2-1 = 2.00 + -0.23 * mean_s10
R-Square = 0.02
 
 
 
 
